Page last updated: 2024-08-17

androstenedione and Breast Neoplasms

androstenedione has been researched along with Breast Neoplasms in 353 studies

Research

Studies (353)

Timeframe	Studies, this research(%)	All Research%
pre-1990	128 (36.26)	18.7374
1990's	129 (36.54)	18.2507
2000's	61 (17.28)	29.6817
2010's	32 (9.07)	24.3611
2020's	3 (0.85)	2.80

Authors

Authors	Studies
Barmade, MA; Murumkar, PR; Tamboli, RS; Yadav, MR	1
Chatterton, RT	1
Kar, SP; Nounu, A; Relton, CL; Richmond, RC	1
Kostecká, Z; Očenáš, P; Salayová, A; Valko-Rokytovská, M	1
Alonso-Diez, A; Caceres, S; de Andres, PJ; Illera, JC; Illera, MJ; Monsalve, B; Peña, L; Reuben, JM; Silvan, G; Woodward, WA	1
Abderrahman, B; Jordan, VC	1
Bao, Z; Deng, H; Gao, L; Li, J; Li, X; Liu, L; Nie, D; Rong, Z; Teichmann, AT; Wang, G; Wieland, FH; Yang, Y	1
Bane, FT; Bleach, R; Creevey, L; Hill, AD; Madden, SF; McIlroy, M; Toomey, S; Varešlija, D; Young, LS	1
Brodie, A; Golubeva, O; Kazi, A; Sabnis, GJ; Shah, P	1
O'Hanlon, LH	1
Marti, A; Martin, GD; Narvaez, J	1
Barman, P; Buzdar, AU; Desta, Z; Dudenkov, TT; Flockhart, DA; Goetz, MP; Ingle, JN; Kalari, KR; Northfelt, DW; Perez, EA; Robson, ME; Wang, L; Weinshilboum, RM; Williard, CV	1
Andò, S; Barone, I; Brown, PH; Fuqua, SA; Iacopetta, D; O'Malley, BW; Rechoum, Y; Rovito, D; Weigel, NL	1
Castillo, R; Martí, S; Viciano, I	1
Chatterton, RT; Dorgan, JF; Kapoor, R; Puleo, E; Ronnenberg, A; Seeram, NP; Sturgeon, SR	1
Ballard, R; Baumgartner, KB; Baumgartner, RN; Bernstein, L; Campbell, K; Duggan, C; McTiernan, A; Neuhouser, ML; Stanczyk, F	1
Martí, S; Viciano, I	1
Alcaro, S; Amaral, C; Carvalho, RA; Correia-da-Silva, G; Costa, G; Costa, SC; Roleira, FM; Tavares-da-Silva, EJ; Teixeira, NA; Varela, CL	1
Abrams, DN; Joshua, AV; McEwan, AJ; Sharma, SK; Zheng, W	1
Colombo, G; Dinis, TC; Neves, MA; Sá e Melo, ML	1
Blair, IA; Byrns, MC; Duan, L; Lee, SH; Penning, TM	1
Brueggemeier, RW; Darby, M; Koynova, R; Lee, LJ; Lee, RJ; Li, H; Mao, Y; Piao, L; Sugimoto, Y; Weecharangsan, W; Xu, S; Yang, X; Yu, B; Zheng, Y	1
Ballard-Barbash, R; Boyd, NF; Brant, RF; Campbell, KL; Courneya, KS; Friedenreich, CM; Irwin, ML; Jones, CA; Karvinen, KH; McNeely, ML; McTiernan, A; Stanczyk, FZ; Terry, T; Wang, Q; Woolcott, CG; Yaffe, MJ; Yasui, Y	1
Cavaliere, C; Corvigno, S; Galgani, M; Limite, G; Nardone, A; Veneziani, BM	1
Roy, K; Roy, PP	1
Chen, S; Hong, Y; Rashid, R	1
Bryk, M; Chatterton, RT; Habe-Evans, M; Khan, SA; Parker, NP; Scholtens, DM	1
Gallicchio, L; Helzlsouer, KJ; Macdonald, R; Rushovich, E; Wood, B	1
Harada, N; Hayashi, S; Hirose, M; Honma, N; Horiguchi, S; Kuroi, K; Saji, S; Utsumi, T	1
Brinton, LA; Falk, RT; Figueroa, JD; Garcia-Closas, M; Gentzschein, E; Ioffe, OB; Lissowska, J; Sherman, ME; Stanczyk, FZ	1
Burnell, M; Dawnay, A; Ford, J; Fourkala, EO; Gentry-Maharaj, A; Gunu, R; Hasenbrink, G; Jacobs, I; Lichtenberg-Fraté, H; Menon, U; Soromani, C; Widschwendter, M; Zaikin, A	1
Afanasyeva, Y; Arslan, AA; Kaaks, R; Koenig, KL; Liu, M; Rinaldi, S; Scarmo, S; Shore, RE; Toniolo, P; Zeleniuch-Jacquotte, A	1
Cheng, FX; Fu, J; Li, WH; Liu, GX; Shen, ZH; Tang, Y	1
Bane, F; Byrne, C; Conroy, RM; Gaora, PÓ; Hao, Y; Hill, AD; McBryan, J; McIlroy, M; O'Hara, J; Tibbitts, P; Vareslija, D; Young, LS	1
Khan, F; Misra, L; Prakash, O; Sangwan, RS	1
Gildea, JJ; Wang, J; Yue, W	1
Razavi, P; Stancyzk, FZ; Tseng, CC; Vigen, C; Wu, AH	1
Andò, S; Bonofiglio, D; Carpino, A; Maggiolini, M; Marsico, S; Pezzi, V; Picard, D; Rago, V; Vivacqua, A	1
Dixon, JM; Miller, WR; Sahmoud, T; Stuart, M	1
Jiang, Z; Liu, X; Song, S; Wang, T; Wu, S; Yu, J	1
Barton, BA; Buckman, DW; Chandler, DW; Dorgan, JF; Franklin, FA; Friedman, LA; Greenhut, SF; Hunsberger, SA; Kwiterovich, PO; Lasser, NL; Lauer, RM; McMahon, RP; Patterson, BH; Schatzkin, A; Snetselaar, LG; Stevens, VJ; Taylor, PR; Van Horn, L; Yanovski, JA	1
Briand, P; Jensen, J; Kitlen, JW; Labrie, F; Lykkesfeldt, AE	1
Andò, S; Catalano, S; Giordano, C; Marsico, S; Mauro, L; Panno, ML; Rizza, P	1
Dowsett, M; Smith, IE	1
Burton, G; Kleeberg, U; Mauriac, L; Osborne, CK; Robertson, JF; Vergote, I	1
Carlini, P; Cognetti, F; Colella, E; Di Cosimo, S; Fabi, A; Ferretti, G; Frassoldati, A; Papaldo, P; Romiti, A; Ruggeri, EM; Tomao, S; Tonachella, R	1
BACIGALUPO, G; FRANKENBERG, G; SCHUBERT, K	2
Agren, A; Berglund, G; Janzon, L; Johansson, R; Kaaks, R; Lenner, P; Manjer, J	1
Aspinall, SR; Bliss, RD; Cook, DB; Griffith, CD; Griffiths, AB; Lennard, TW; Shenton, BK	1
Brinton, LA; Daling, J; Dorgan, JF; Malone, KE; Potischman, N; Schairer, C; Sturgeon, SR	1
Asseryanis, E; Hellan, M; Kubista, E; Ruecklinger, E; Singer, CF	1
Bajetta, E; Bichisao, E; Bidoli, P; Bombardieri, E; La Torre, I; Longarini, R; Martinetti, A; Portale, T; Seregni, E; Zilembo, N	1
Colditz, GA; Hankinson, SE; Laden, F; Rosner, B; Schernhammer, ES; Willett, WC	1
Day, NE; Dowsett, M; Dunning, AM; Easton, DF; Folkerd, E; Healey, CS; Kelemen, L; Luben, RN; Novik, KL; Ogata, S; Pharoah, PD; Ponder, BA; Tee, L	1
Bai, C; Chen, F; Freedman, L; Gambone, C; Harada, S; Kasparcova, V; Knecht, K; Leu, C; Reszka, A; Rutledge, SJ; Scafonas, A; Schmidt, A; Vogel, R; Zhang, H	1
Grobbee, DE; Onland-Moret, NC; Peeters, PH; van der Schouw, YT; van Gils, CH	1
Barbieri, RL; Eliassen, AH; Hankinson, SE; Missmer, SA	1
Agostara, B; Bronte, G; Campisi, I; Carruba, G; Castagnetta, L; Cocciadiferro, L; Granata, OM; Polito, L; Rizzo, S; Saetta, A	1
Cos, S; Martínez-Campa, C; Mediavilla, MD; Sánchez-Barceló, EJ	1
Lykkesfeldt, AE; Sonne-Hansen, K	1
Delozier, T; Khayat, D; Spano, JP	1
Bria, E; Carlini, P; Cognetti, F; Di Cosimo, S; Fabi, A; Felici, A; Ferretti, G; Giannarelli, D; Milella, M; Mottolese, M; Nisticò, C; Papaldo, P; Ruggeri, EM; Terzoli, E	1
Andrews, S; Braun, DP; Crist, KA; Parker, J; Shaheen, F; Staren, ED	1
Anker, G; Dowsett, M; Ekse, D; Geisler, J; Haynes, B; Helle, H; Lønning, PE	1
Arteaga, CL; Miller, T; Shin, I	1
He, X; Liu, B; Qu, G; Su, L; Wang, G; Wang, X; Yao, X	1
Brodie, A; Guo, Z; Macedo, LF; Qiu, Y; Sabnis, GJ; Tilghman, SL	1
Ioannidis, JP; Mauri, D; Pavlidis, N; Polyzos, NP	1
Prosperi, JR; Robertson, FM	1
Borja-Cacho, E; Damián-Matsumura, P; García-Becerra, R; González, L; Larrea, F; Lemus, AE; Pérez-Palacios, G; Santillán, R	1
Maskarinec, G; Morimoto, Y; Murphy, SP; Stanczyk, FZ; Takata, Y	1
Haiman, CA; Henderson, BE; Le Marchand, L; Setiawan, VW; Stanczyk, FZ	1
Dowsett, M; Ekse, D; Geisler, J; Haynes, B; Lønning, PE	1
Freudenstein, J; Nisslein, T	1
Brodie, A; Goloubeva, O; Jelovac, D; Sabnis, G; Schayowitz, A	1
Blanchett, D; Demers, L; Goss, PE; Langecker, P; Ohorodnik, S; Santen, RJ; Settlage, J; Wang, S	1
Bjurstam, N; Bremnes, Y; Gram, IT; Kaaks, R; Rinaldi, S; Ursin, G	1
Miki, Y; Sasano, H	1
Hoover, RN; Innes, KE; Roberts, JM; Troisi, R	1
Brodie, A; Goloubeva, O; Macedo, L; Sabnis, GJ; Schayowitz, A; Zhu, Y	1
Blanchett, D; Bondarenko, IN; Goss, P; Langecker, P; Manikhas, GN; Miller, WH; Pendergrass, KB	1
Dutta, U; Pant, K	1
Cavaliere, C; Ciardiello, F; Corvigno, S; Criniti, V; De Placido, S; Limite, G; Nardone, A; Picarelli, S; Tortora, G; Veneziani, BM	1
Brodie, A; Coombes, RC; Dowsett, M; Gazet, JC; Goss, P	1
Killinger, DW; Perel, E	1
Abul-Hajj, YJ	3
Dowsett, M; Harris, AL; Jeffcoate, SL; McKinna, JA; Morgan, M; Smith, IE	1
Bodrogi, L; Fehér, T; Ribai, Z; Vallent, K	2
Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE	2
Dowsett, M; Harris, AL; Jeffcoate, S; Smith, IE	1
Smith, IE; Stuart-Harris, RC	1
Blaustein, A; Levitz, M; Raju, U	1
Limone, P; Molinatti, GM	1
Doorenbos, H; Pratt, JJ; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH	1
Beranek, PA; Folkerd, EJ; Ghilchik, MW; James, VH	1
Powles, TJ	1
Samojlik, E; Santen, RJ	2
Deshpande, N; Di Martino, L; Mitchell, I; Tarquini, A	1
Davis, TE; Rose, DP	2
Siiteri, PK	1
Samojlik, E; Santen, RJ; Wells, SA; Worgul, TJ	1
Boffard, K; Bulbrook, RD; Clark, GM; Irvine, JB; Knyba, RE; Kwa, HG; Wang, DY	1
Feil, PD; Santen, RJ; Santner, SJ; Tilson-Mallett, N	1
Blackstein, ME; Kharlip, L; Killinger, DW; Perel, E; Stolee, KH	1
Brodie, AM	3
Covey, DF; Hood, WF	1
Dao, TL	1
Blackstein, ME; Killinger, DW; Perel, E	1
Covey, DF; Etre, LA; MacIndoe, JH; Woods, GR	1
Barone, RM; Gambone, JC; Judd, HL; Lasley, BL; Laufer, LR; Monfort, SL	1
Forrest, AP; Hawkins, RA; Miller, WR	1
Davis, S; Killinger, DW; Perel, E	1
Deshpande, N; Di Martino, L; Poortman, J; Schwarz, F; Tarquini, A; Thijssen, JH; Van Landeghem, AA	1
Covey, DF; Davis, SP; Killinger, DW; Perel, E	1
Folkerd, EJ; James, VH; Reed, MJ	1
Check, WA	1
Killinger, DW; Perel, E; Wilkins, D	1
Budnick, RM; Dao, TL	1
Adlercreutz, H; Anker, GB; Ekse, D; Fotsis, T; Hall, K; Helle, SI; Johannessen, DC; Lien, EA; Lønning, PE; Tally, M	1
Murray, R; Pitt, P	2
McTavish, D; Wiseman, LR	1
Berstein, LM; Brodie, AM; Koos, RD; Naftolin, F; Santen, RJ; Santner, SJ	1
Dowsett, M; Jacobs, S; Lonning, PE; MacNeill, FA; Powles, TJ	1
Bajetta, E; Biasi, G; Bichisao, E; Bono, A; Buzzoni, R; Dolci, S; Laffranchi, A; Noberasco, C; Vicario, G; Zilembo, N	1
Attili, A; Bajetta, E; Bartoli, C; Buzzoni, R; Ferrari, L; Lepera, P; Martinetti, A; Noberasco, C; Sacchini, V; Zilembo, N	1
Alberola Candel, V; Calabresi, F; Delozier, T; Feuilhade, F; Freue, M; Goss, P; Mauriac, L; Michel, RT; Pérez Carrión, R; Santos, R	1
Dowsett, M	4
Höffken, K; Jonat, W; Possinger, K	1
Miller, WR; Parker, MG; Sourdaine, P; Telford, J	1
Duncan, LJ; Ghilchick, MW; Macdiarmid, F; Purohit, A; Reed, MJ; Wang, D	1
Bajetta, E; Buzzoni, R; Celio, L; Dolci, S; Ferrari, L; Laffranchi, A; Noberasco, C; Vicario, G; Zilembo, N	1
Brodie, AM; Santen, RJ	2
Brueggemeier, RW	1
Reed, MJ	1
Coombes, RC; Dowsett, M	1
Bajetta, E; Buzzoni, R; Celio, L; Cerrotta, AM; Ferrari, L; Galante, E; Martinetti, A; Noberasco, C; Orefice, S; Zilembo, N	1
Cassoni, P; Cenderelli, G; Massobrio, M; Menzaghi, C; Migliardi, M; Revelli, A	1
Bajetta, E; Bartoli, C; Buzzoni, R; Celio, L; Di Leo, A; Merson, M; Moglia, D; Noberasco, C; Sacchini, V; Zilembo, N	1
Alberg, AJ; Bush, TL; Comstock, GW; Gordon, GB; Helzlsouer, KJ; Longcope, C	1
Brown, C; Campbell, WS; Dorgan, JF; Franz, C; Judd, JT; Kahle, L; Longcope, C; Reichman, ME; Schatzkin, A; Taylor, PR	1
Adlercreutz, H; Fotsis, T; Johannessen, DC; Lønning, PE	1
Dowsett, M; Jacobs, S; Lønning, PE; MacNeill, FA; Powles, TJ	1
Bélanger, A; Bélanger, B; Fiet, J	1
Chen, S; Korsunsky, Z; Martel, J; Santen, RJ; Santner, SJ; Zhou, D	1
Kanno, H; Kim, T; Kitawaki, J; Noguchi, T; Okada, H; Yamamoto, T	1
Brodie, A; Yue, W	1
Bajetta, E; Bichisao, E; Buzzoni, R; Celio, L; Noberasco, C; Zilembo, N	1
Höffken, K	1
Maggino, T; Marcadella, CB; Romagnolo, C	2
Ekse, D; Lønning, PE	1
Detre, S; Dowsett, M; Grimshaw, R; Lee, K; Macaulay, VM; Rowlands, M	1
Coombes, RC; Corbishley, C; Ford, HT; Gazet, JC; Griffin, M; Lowndes, S; Makinde, V; Quilliam, J; Sutcliffe, R	1
Adami, HO; Carlström, K; Lipworth, L; Mantzoros, C; Trichopoulos, D	1
Henderson, BE; Ursin, G	1
Goa, KL; Wiseman, LR	1
Detre, S; Dowsett, M; Grimshaw, R; Rowlands, M	1
Frost, VJ; Helle, SI; Holly, JM; Lønning, PE; van der Stappen, JW	1
Bos-Zuur, I; de la Rivière, GB; Dikkeschei, LD; Nagel, GT; van der Kolk, DA; Willemse, PH; Wolthers, BG	1
Anker, G; Geisler, J; Johannessen, DC; Lønning, PE	1
Brankin, E; Gallagher, A; Soukop, M	1
Rose, C	1
Campbell, WS; Dorgan, JF; Falk, RT; Franz, C; Kahle, L; Longcope, C; Miller, R; Schatzkin, A; Stephenson, HE; Tangrea, JA	1
Bajetta, E; Bombardieri, E; Ferrari, L; Martinetti, A; Massaron, S; Noberasco, C; Rimassa, L; Seregni, E; Zilembo, N	1
Amichetti, M; Attili, A; Bajetta, E; Barni, S; Bichisao, E; Bolelli, GF; Bombardieri, E; Buzzoni, R; Comella, G; D'Aprile, M; Ferrari, L; Jirillo, A; Martinetti, A; Noberasco, C; Schieppati, G; Zilembo, N	1
Bershteĭn, LM; Kriukova, OG; Larionov, AA	1
Durgam, VR; Tekmal, RR	1
Baker, D; Brueggemeier, RW; Darby, MV; Gilbert, NE; Gu, XJ; Lovely, CJ; O'Reilly, JM; Quinn, AL; Ward, PJ	1
Buzdar, AU; Roseman, BJ; Singletary, SE	1
Bonnefoi, H; Castiglione, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hsu-Schmitz, SF; Löhnert, T; Morant, R; Thürlimann, B	1
Rubens, RD	1
Anderson, ED; Anderson, TJ; Cameron, DA; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC; Levack, P	1
Aparicio, LA; Carrion, RP; Dodwell, DJ; Dowsett, M; Kleeberg, UR; Robertson, JF; Vorobiof, DA	1
Bershteĭn, LM; Larionov, AA; Poroshina, TE; Uporov, AV; Zimarina, TS	1
Dickson, RB; El-Ashry, D; Hannum, RS; Kern, FG; Kharbanda, S; Lopez, CA; Lorant, LA; McLeskey, SW; Tobias, CA; Trock, BJ; Zhang, L	1
Brinton, LA; Dorgan, JF; Hoover, RN; Madigan, MP; Potischman, N; Troisi, R	1
Berstein, LM; Kovalenko, IG; Larionov, AA; Poroshina, TE; Uporov, AV; Zimarina, TS	1
Ekse, D; Giurescu, M; Helle, SI; Holly, JM; Jonat, W; Lønning, PE	1
Anker, G; Di Salle, E; Dowsett, M; Geisler, J; King, N; Lønning, PE; Ornati, G	1
Lønning, PE	1
Dowsett, M; Jacobs, S; Johnston, SR; Jones, A; Smith, IE; Trunet, P	1
Helle, SI; Lonning, PE; Lundgren, S	1
Alonso, MC; Español, I; Muñíz-Díaz, E; Pujol-Moix, N	1
Brodie, AM; Grigoryev, DN; Long, BJ; Thiantanawat, A; Tilghman, SL; Yue, W	1
Coombes, RC	2
Anker, GB; Johannessen, DC; Lien, EA; Lonning, PE; Refsum, H; Ueland, PM	1
Andrés, E; Dufour, P; Goichot, B; Imler, M; Kurtz, JE; Schlienger, JL	1
Brodie, AM; Dehal, SS; Kupfer, D	1
Browner, W; Cauley, JA; Cummings, SR; Kuller, LH; Lucas, FL; Stone, K	1
Blijham, GH; de Jong, PC	1
Coombes, RC; Harper-Wynne, C	1
Coombes, RC; Doody, D; Dowsett, M; English, J; Howes, A; Miall, S	1
Bernhard, J; Bonnefoi, H; Castiglione-Gertsch, M; Cavalli, F; Fey, MF; Goldhirsch, A; Hürny, C; Morant, R; Schmitz, SF; Thürlimann, B	2
Bonneterre, J; Feutrie, ML	1
Calvo, L; Clack, G; Dodwell, DJ; Dowsett, M; Kleeberg, UR; Perez-Carrion, R; Robertson, JF; Vorobiof, DA	1
Fukuda, M; Shimizu, S; Suda, T; Watanabe, H	1
Brodie, AM; Njar, VC	1
Diep, AT; Haile, RW; Henderson, BE; Ingles, SA; Kolonel, LN; Probst-Hensch, NM; Stanczyk, FZ	1
Coombes, RC; Dowsett, M; Harper-Wynne, C	1
Harvey, HA; Santen, RJ	1
Bajetta, E; Bichisao, E; Pozzi, P; Toffolatti, L; Zilembo, N	1
Joseph, JK; Lim, AK	1
Audisio, RA; Castiglione, F; Comandini, D; Granetto, C; Repetto, L; Ross, R; Venturino, A	1
Bajetta, E; Bombardieri, E; Celio, L; Di Bartolomeo, M; Ferrari, L; Mariani, L; Martinetti, A; Miceli, R; Pozzi, P; Seregni, E; Toffolatti, L; Zilembo, N	1
Klinga, K; Mayer, D; Morfin, R; Schmitt, M; Schnarr, B	1
Kerbrat, P; Lefeuvre, C	1
Boudou, P; Dorgan, JF; Falk, RT; Longcope, C; Schussler, N; Stanczyk, FZ; Stephenson, HE; Tejpar, AA	1
Blum, W; Faigle, JW; Galli, B; Geisler, J; Gschwind, HP; Johannessen, DC; Kriemler, HP; Lønning, PE; Miller, WR; Schneider, W; Waldmeier, F; Winkler, T	1
Coombes, RC; Ford, HT; Gazet, JC; Gray, R; Lowndes, S; Makinde, V; McConkey, C; Quilliam, J; Sutcliffe, R	1
Buzdar, A; Howell, A	1
Ahotupa, M; Ammälä, J; Joshi, SC; Li, X; Mäkelä, S; Saarinen, N; Santti, R	1
Carlini, P; Casali, A; Cognetti, F; De Marco, S; Fabi, A; Frassoldati, A; Nardi, M; Paoloni, F; Papaldo, P; Ruggeri, EM	1
Appleby, P; Barnes, I; Key, T; Reeves, G	1
Lombardi, P	1
Harvey, H; Lipton, A; Samojlik, E; Santen, RJ; Veldhuis, J; Wells, SA	1
Deshpande, N	1
Helman, P; Hickman, R; Hill, P; Rona, G; Wynder, EL	1
Helman, P; Hickman, R; Hill, P; Kuno, K; Rona, G; Wynder, EL	1
Carson, P; Deshpande, N; Di Martino, L; Tarquini, A	1
Becciolini, A; Calabresi, E; De Giuli, G; Giannotti, P; Lombardi, G; Serio, M	1
Crowley, JJ; Milbrath, JR; Rose, DP; Stauber, P; Thiel, A	1
Bulbrook, RD; Hayward, JL; Wang, DY	1
Borkowski, A; Dor, P; L'hermite, M; Longeval, E; Muquardt, C; Rozencweig, M; Van Cauter, E	1
Alksne, JF; Lachelin, GC; Yen, SC	1
Bulbrook, RD; Hayward, JL; Hoare, SA; Moore, JW; Thomas, BS; Tong, D; Wang, DY	1
Abul-Hajj, YJ; Iverson, R; Kiang, DT	1
Poortman, J; Prenen, JA; Schwarz, F; Thijssen, JH	1
Poortman, J; Schwarz, F; Thijssen, JH	2
Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA	1
Nimrod, A; Ryan, KJ	1
Davis, B; Ruby, E; Samojlik, E; Santen, RJ; Santner, S; Veldhuis, J	1
Barone, RM; Judd, HL	1
Barone, RM; Judd, HL; Shamonki, IM; Siiteri, PK	1
D'Agata, R; Lippman, ME; Loriaux, DL; Monaco, ME	1
Cohen, FB; Kirschner, MA; Ryan, C	1
Adami, HO; Johansson, ED; Vegelius, J; Victor, A	1
Brown, PW; Lawrence, W; Newsome, HH; Terz, JJ	1
Forrest, AP; Miller, WR; Shivas, AA	1
Dilley, WG; Haagensen, DE; Harvey, H; Lipton, A; Ruby, EJ; Santen, RJ; Wells, SA	1
Dao, TL; Varela, RM	1
Levitz, M; Post, J; Raju, U; Sklarew, RJ	1
de Waard, F; Poortman, J; Schwarz, F; Thijssen, JH	1
Poortman, J; Schwarz, F; Thijssen, JH; Vroegindewey-Jie, D	1
Samojlik, E; Santen, RJ; Wells, SA	1
Lipsett, MB	1
Polansky, S	1
Dunning, MT; Pinkus, GS; Rose, LI; Underwood, RH; Williams, GH	1
Forrest, AP; Miller, WR	2
Christodoulides, A; Ghilchik, MW; Koistinen, R; Reed, MJ; Seppälä, M; Teale, JD	1
Borja, J; Pérez, N	1
Coombes, RC; Dowsett, M; Stein, RC	1
Blankenstein, MA; Daroszewski, J; Donker, GH; Maitimu-Smeele, I; Milewicz, A; Thijssen, JH	1
Bhatavdekar, JM; Ghosh, N; Giri, DD; Karelia, NH; Patel, DD; Shah, NG; Suthar, TP; Trivedi, SN; Vora, HH	1
Dowsett, M; Jacobs, S; Jones, AL; Lonning, PE; MacNeill, F; Powles, TJ	1
Hisamatsu, K; Nomura, Y; Tashiro, H	1
Coombes, RC; Dowsett, M; Hughes, SW	1
Dowsett, M; Ekse, D; Jacobs, S; Johannessen, DC; Jones, A; Lønning, PE; McNeil, F; Powles, TJ	1
James, VH; Purohit, A; Reed, MJ	1
Beattie, CW; Das Gupta, TK; Mehta, RR	1
Coombes, RC; Dowsett, M; King, N; Mehta, A; Powles, TJ; Smith, IE; Stein, RC	1
Barrett-Connor, E; Friedlander, NJ; Garland, CF; Khaw, KT	1
Demers, LM; Garber, JE; Hanagan, J; Harvey, H; Henderson, IC; Lipton, A; Lynch, J; Mulagha, M; Navari, RM; Santen, RJ	1
Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A	1
Dowsett, M; Griggs, L; Haynes, B; Jacobs, S; Lønning, PE	1
Bellora, MG; Bergamino, T; Ciancio, A; Ferrero, A; Sismondi, P; Zola, P	1
Coombes, RC; Ford, HT; Gazet, JC	1
Anderson, ED; Anderson, TJ; Chetty, U; Forrest, AP; Hawkins, RA; Leonard, RC	1
Dowsett, M; Haynes, B; Jacobs, S; Jones, A; Lønning, PE; Powles, T	1
Bellantone, R; Crucitti, F; De Marinis, L; Di Pietro, C; Liberale, I; Lombardi, CP; Mancini, A; Menini, E; Rossi, S	1
Dowsett, M; Firth, J; Jarman, M; Poon, GK; Rowlands, MG	1
Aherne, GW; Chakraborty, J; Ghilchik, MW; Patel, S; Reed, MJ	1
Brodie, A	1
Dowsett, M; Richner, J	1
Dowsett, M; Lønning, PE; Powles, TJ	1
Dikkeschei, LD; Sleijfer, DT; Tjabbes, T; van Veelen, H; Willemse, PH	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Reed, MJ; Shaikh, NA	1
Coombes, RC; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC	1
Distler, W; von Matthiessen, H	1
Eidtmann, H; Jonat, W; Kügler, G; Kunz, T; Maass, H	1
Santen, RJ	1
Becher, R; Callies, R; Friederich, P; Höffken, K; Jonat, W; Kölbel, M; Kunz, T; Possinger, K; Wagner, H; Willmanns, W	1
Banks, PK; Brodie, AM; Coombes, RC; Dowsett, M; Inkster, SE	1
Banks, PK; Brodie, AM; Inkster, SE; Koos, RD; Son, C	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Owen, AM; Purohit, A; Reed, MJ; Shaikh, NA; Singh, A	1
Coombes, RC; Davenport, J; Dowsett, M; Ford, HT; Gazet, JC; Hedley, A; Stein, RC	1
Murray, P; Perry, L; Pickles, T; Plowman, P	1
Henderson, D	1
Berrino, F; Cavalleri, A; Di Pietro, S; Fariselli, G; Pisani, P; Recchione, C; Secreto, G; Toniolo, P; Totis, A	1
Anderson, ED; Chetty, U; Forrest, AP; Hawkins, RA; Levack, PA	1
Miller, WR	1
Blamey, RW; Nicholson, RI; Read, GF; Robertson, JF; Turkes, A; Walker, KJ; Walker, RF	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Purohit, A; Reed, MJ; Singh, A	1
Dowsett, M; Hardy, J; Jacobs, S; Lønning, PE; Powles, TJ; Schem, B	1
Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Moolenaar, AJ; Nooijen, WJ; van der Linden, E	1
Alexieva-Figusch, J; Bakker, GH; de Jong, FH; Klijn, JG; Lamberts, SW; Rodenburg, CJ	1
de Launoit, Y; Decoster, R; Deslypere, JP; Kiss, R; Lescrainier, JP; Paridaens, R; Pasteels, JL; Vokaer, A; Wouters, W	1
Antonio, P; Bolufer, P; Rodriguez, A; Salabert, MT; Teruel, M	1
Coldham, NG; Ghilchik, MW; James, VH; Lai, LC; Owen, AM; Reed, MJ; Shaikh, NA	1
Boice, JD; Eby, NL; Gold, EB; Hoover, RN; Loriaux, DL	1
Manni, A; Santen, RJ	1
Coombes, RC; Cunningham, DC; Dehennin, L; Dowsett, M; Evans, S; Hedley, A; Stein, RC	1
Adlercreutz, H; Dwyer, JT; Goldin, BR; Gorbach, SL; Hämäläinen, E; Woods, MN	1
Cantwell, BM; Dowsett, M; Harris, AL; Hill, M; Jeffcoate, SL; Smith, IE; Stuart-Harris, R	1
Brodie, AM; Coombes, RC; Dowsett, M; Gazet, JC; Goss, PE; Hutchison, G; Powles, TJ	1
Cantwell, BM; Dowsett, M; Farndon, J; Harris, AL; Needham, G; Sainsbury, JR; Wilson, R	1
Dowsett, M; Jeffcoate, SL; Lal, A; Smith, IE	1
Alexieva-Figusch, J; de Jong, FH; Klign, JG; Lamberts, WJ; van Gilse, HA	1
Cantwell, BM; Dowsett, M; Harris, AL	1
D'Souza, A; Donaldson, A; Dowsett, M; Harris, AL; Jeffcoate, SL; Smith, IE; Stuart-Harris, R	1
Beranek, PA; Bonney, RC; Franks, S; Ghilchik, MW; James, VH; Newton, CJ; Reed, MJ; Samuel, DL	1
Das Gupta, TK; Graves, J; Green, R; Mehta, RR; Valcourt, L	1
Doorenbos, H; Sleijfer, DT; Sluiter, WJ; van der Ploeg, E; van Veelen, H; Willemse, PH	1
Doorenbos, H; Sleijfer, DT; Sluiter, WJ; van Veelen, H; Willemse, PH	1
Baker, D; Labrie, F; Poulin, R	1
Brandt, ME; Covey, DF; Fendl, K; Garola, R; Puett, D; Zimniski, SJ	1
Brodie, AM; Coombes, RC; Dowsett, M	1
Blackstein, M; Daniilescu, D; Kharlip, L; Killinger, DW; Perel, E	1
Miller, WR; O'Neill, J	1
Feil, PD; Leszczynski, D; Manni, A; Santen, RJ; Santner, SJ; Tilson-Mallet, N; Wright, C	1
Bezwoda, WR; Dansey, R; Esser, JD; Mansoor, N	1
Brueggemeier, RW; Katlic, NE	1
Brodie, AM; Coombes, RC; Cunningham, D; Dowsett, M; Ford, HT; Gazet, JC; Hutchison, G; Powles, TJ	1
Brodie, AM; Coombes, RC; Dowsett, M; Goss, P; Wing, LY	2
Coombes, RC; Easton, D; Goss, PE; Singh, D; Wilkinson, JR; Williams, JC	1
Griffiths, K; Maynard, PV; Mistry, P	1
Brodie, AM; Coombes, RC; Dowsett, M; Goss, PE; Hutchinson, G; Jeffcoate, SL; Powles, TJ	1
Blackstein, ME; Daniilescu, D; Kharlip, L; Killinger, DW; Perel, E	1
Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J	1
Dowsett, M; Jeffcoate, SL; Santen, RJ; Santner, SJ; Smith, IE	1
Beardwell, CG; Bu'lock, D; Hindley, AC; St John, J; Wilkinson, PM	1
Finkelstein, M; Geier, A; Horn, H; Levij, IS; Lichtshtein, E	1
Karl, HJ; Raith, L; Wirtz, A	1

Reviews

62 review(s) available for androstenedione and Breast Neoplasms

Article	Year
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer. European journal of medicinal chemistry, 2015, Nov-13, Volume: 105 Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Female; Humans; Models, Molecular; Molecular Structure	2015
Functions of dehydroepiandrosterone in relation to breast cancer. Steroids, 2022, Volume: 179 Topics: Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Testosterone	2022
Breast Cancer: Targeting of Steroid Hormones in Cancerogenesis and Diagnostics. International journal of molecular sciences, 2021, May-30, Volume: 22, Issue:11 Topics: Androstenedione; Biomarkers, Tumor; Breast Neoplasms; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Female; Gas Chromatography-Mass Spectrometry; Humans; Immunoassay; Metabolic Networks and Pathways; Metabolomics; Recurrence; Tandem Mass Spectrometry	2021
[Progress in study of the structure, catalytic mechanism and inhibitors of aromatase]. Yao xue xue bao = Acta pharmaceutica Sinica, 2012, Volume: 47, Issue:1 Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Catalysis; Coumarins; Estrogens; Flavonoids; Humans; Inhibitory Concentration 50; Letrozole; Nitriles; Sesquiterpenes; Structure-Activity Relationship; Triazoles; Xanthones	2012
Aromatase inhibitors in breast cancer. The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24 Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Premenopause	2003
Sex steroids, carcinogenesis, and cancer progression. Annals of the New York Academy of Sciences, 2004, Volume: 1028 Topics: Adsorption; Androstenedione; Animals; Breast Neoplasms; Catalysis; Catechols; Cell Line, Tumor; Chromatography, High Pressure Liquid; Disease Progression; Estradiol; Estrogens; Humans; In Vitro Techniques; Ions; Kinetics; Models, Biological; Neoplasms; Steroids; Time Factors	2004
[Aromatase inhibitors in adjuvant setting in breast cancer]. Bulletin du cancer, 2004, Dec-01, Volume: 91 Suppl 4 Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Menopause; Nitriles; Triazoles	2004
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials. Cancer, 2005, Oct-01, Volume: 104, Issue:7 Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Probability; Prognosis; Remission Induction; Risk Assessment; Survival Analysis; Triazoles	2005
Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. Journal of the National Cancer Institute, 2006, Sep-20, Volume: 98, Issue:18 Topics: Adult; Aged; Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Letrozole; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Odds Ratio; Randomized Controlled Trials as Topic; Survival Analysis; Triazoles	2006
[Intracrinology of human breast carcinoma and aromatase]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Jun-28, Volume: 65 Suppl 6 Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Estrogens; Female; Humans	2007
Aromatase inhibitors: past, present and future in breast cancer therapy. Medical oncology (Northwood, London, England), 2008, Volume: 25, Issue:2 Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles	2008
Aminoglutethimide in the treatment of advanced breast cancer. Cancer treatment reviews, 1984, Volume: 11, Issue:3 Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
[Hormones and breast cancer. Current views]. Minerva medica, 1982, Apr-21, Volume: 73, Issue:17 Topics: Androstenedione; Animals; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Prolactin; Rats; Receptors, Cell Surface; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Testosterone	1982
Extraglandular oestrogen formation and serum binding of oestradiol: relationship to cancer. The Journal of endocrinology, 1981, Volume: 89 Suppl Topics: Adipose Tissue; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrogens; Female; Humans; Liver; Male; Obesity; Pregnancy; Protein Binding; Sex Hormone-Binding Globulin; Testosterone; Uterine Neoplasms	1981
Formestane. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer. Drugs, 1993, Volume: 45, Issue:1 Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; In Vitro Techniques; Male; Prostatic Neoplasms	1993
Aromatase and its inhibitors in breast cancer treatment--overview and perspective. Breast cancer research and treatment, 1994, Volume: 30, Issue:1 Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Steroids	1994
Aromatase inhibitors--mechanisms of steroidal inhibitors. Breast cancer research and treatment, 1994, Volume: 30, Issue:1 Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Drug Design; Female; Humans; Neoplasms, Hormone-Dependent; Steroids; Structure-Activity Relationship	1994
The role of aromatase in breast tumors. Breast cancer research and treatment, 1994, Volume: 30, Issue:1 Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; DNA Polymerase II; Estrogens; Estrone; Female; Humans; Prognosis; Receptors, Progesterone; Tumor Cells, Cultured	1994
Second generation aromatase inhibitor--4-hydroxyandrostenedione. Breast cancer research and treatment, 1994, Volume: 30, Issue:1 Topics: Administration, Oral; Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Injections, Intramuscular; Male	1994
Aromatase, its inhibitors and their use in breast cancer treatment. Pharmacology & therapeutics, 1993, Volume: 60, Issue:3 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Half-Life; Humans; Neoplasms, Hormone-Dependent; Pargyline	1993
Formestane for advanced breast cancer in postmenopausal women. Drug and therapeutics bulletin, 1993, Oct-25, Volume: 31, Issue:22 Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Costs and Cost Analysis; Female; Humans; Injections, Intramuscular; Postmenopause	1993
Experience with aromatase inhibitors in the treatment of advanced breast cancer. Cancer treatment reviews, 1993, Volume: 19 Suppl B Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Forecasting; Humans	1993
The control and biological importance of intratumoural aromatase in breast cancer. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 56, Issue:1-6 Spec N Topics: Adenocarcinoma; Androgens; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carcinoma; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Male; Mice; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Nitriles; Triazoles; Tumor Cells, Cultured	1996
Formestane. A review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer. Drugs & aging, 1996, Volume: 9, Issue:4 Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Postmenopause; Rats	1996
Proper sequence of endocrine therapies in advanced breast cancer. Acta oncologica (Stockholm, Sweden), 1996, Volume: 35 Suppl 5 Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Female; Humans; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Premenopause	1996
Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors. The Journal of steroid biochemistry and molecular biology, 1997, Volume: 61, Issue:3-6 Topics: Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Rats	1997
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer. Journal of surgical oncology, 1997, Volume: 66, Issue:3 Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Enzyme Inhibitors; Estrogen Antagonists; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles	1997
Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer. Breast cancer research and treatment, 1998, Volume: 49 Suppl 1 Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Postmenopause	1998
Aromatase inhibitors and their use in the adjuvant setting. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1998, Volume: 152 Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Fadrozole; Female; Humans	1998
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women. The Netherlands journal of medicine, 1999, Volume: 55, Issue:2 Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles	1999
[Aromatase inhibitors]. Bulletin du cancer, 1999, Volume: 86, Issue:10 Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles	1999
Aromatase inhibitors and their application in breast cancer treatment. Steroids, 2000, Volume: 65, Issue:4* Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Mice; Nitriles; Tamoxifen; Triazoles	2000
Drug and hormone interactions of aromatase inhibitors. Endocrine-related cancer, 1999, Volume: 6, Issue:2 Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Interactions; Enzyme Inhibitors; Estrogens; Fadrozole; Female; Humans; Letrozole; Male; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Sensitivity and Specificity; Tamoxifen; Triazoles	1999
Aromatase inhibitors and their use in the sequential setting. Endocrine-related cancer, 1999, Volume: 6, Issue:2 Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Triazoles	1999
Use of aromatase inhibitors in breast carcinoma. Endocrine-related cancer, 1999, Volume: 6, Issue:1 Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles	1999
Steroidal aromatase inhibitors in elderly patients. Critical reviews in oncology/hematology, 2000, Volume: 33, Issue:2 Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles	2000
[Aromatase inhibitors: a review of clinical trials]. Bulletin du cancer, 2000, Volume: 87 Spec No Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles	2000
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:9 Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting	2001
Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. Journal of the National Cancer Institute, 2002, Apr-17, Volume: 94, Issue:8 Topics: Aged; Androstenedione; Breast Neoplasms; Case-Control Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Hormone Replacement Therapy; Humans; Middle Aged; Prospective Studies; Risk; Sex Hormone-Binding Globulin; Testosterone; Time Factors	2002
Exemestane, a new steroidal aromatase inhibitor of clinical relevance. Biochimica et biophysica acta, 2002, Jul-18, Volume: 1587, Issue:2-3 Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Receptor Modulators; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent	2002
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. Cancer, 1977, Volume: 39, Issue:6 Suppl Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dexamethasone; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thyrotropin; Thyroxine	1977
Post-menopausal estrogen production, with special reference to patients with mammary carcinoma. Frontiers of hormone research, 1975, Volume: 3 Topics: Age Factors; Aged; Androgens; Androstenedione; Binding, Competitive; Body Weight; Breast Neoplasms; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Kinetics; Menopause; Middle Aged; Receptors, Estrogen	1975
Hormones, nutrition, and cancer. Cancer research, 1975, Volume: 35, Issue:11 Pt. 2 Topics: Androstenedione; Anovulation; Breast Neoplasms; Estrogens; Estrone; Female; Hormones; Humans; Neoplasms; Nutritional Physiological Phenomena; Obesity; Uterine Neoplasms	1975
Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer. The Journal of international medical research, 1992, Volume: 20, Issue:4 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Letrozole; Nitriles; Triazoles	1992
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3 Topics: Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Estrogens; Female; Goserelin; Humans; Menopause	1992
Inhibition of oestrogen synthesis in postmenopausal women with breast cancer. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3 Topics: Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Arylsulfatases; Breast Neoplasms; Danazol; Estrogens; Female; Humans; Kinetics; Menopause; Steryl-Sulfatase	1992
Aromatase and its inhibitors--an overview. The Journal of steroid biochemistry and molecular biology, 1991, Volume: 40, Issue:1-3 Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Humans	1991
Postmenopausal estrogen synthesis and metabolism: alterations caused by aromatase inhibitors used for the treatment of breast cancer. Journal of steroid biochemistry, 1990, Volume: 35, Issue:3-4 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Fadrozole; Female; Humans; Imidazoles; Menopause; Nitriles	1990
New trends in the endocrine treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1990
Recent progress in development of aromatase inhibitors. The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Humans; Imidazoles; Nitriles	1990
Clinical development of aromatase inhibitors for the treatment of breast and prostate cancer. The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Estrogen Antagonists; Fadrozole; Humans; Imidazoles; Nitriles	1990
Aromatase inhibitors and hormone-dependent cancers. The Journal of steroid biochemistry and molecular biology, 1990, Nov-20, Volume: 37, Issue:3 Topics: Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Humans; Neoplasms, Hormone-Dependent	1990
Aromatase and other inhibitors in breast and prostatic cancer. The Journal of steroid biochemistry and molecular biology, 1990, Dec-20, Volume: 37, Issue:6 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Humans; Male; Prostatic Neoplasms	1990
Aromatase inhibitors: their biochemistry and clinical potential. Journal of steroid biochemistry, 1987, Volume: 27, Issue:4-6 Topics: 17-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Chemical Phenomena; Chemistry; Estrogens; Female; Humans; Male; Oxidoreductases; Prostatic Hyperplasia	1987
Aromatase inhibitors in the treatment of advanced breast cancer. Cancer treatment reviews, 1989, Volume: 16, Issue:2 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Fadrozole; Female; Humans; Imidazoles; Neoplasms, Hormone-Dependent; Nitriles	1989
Clinical use of aromatase inhibitors in the treatment of breast cancer. Cancer treatment and research, 1988, Volume: 39 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrogen Antagonists; Estrogens; Female; Humans	1988
Androgen and estrogen metabolism in breast cancer patients. Annals of the New York Academy of Sciences, 1986, Volume: 464 Topics: 17-Hydroxysteroid Dehydrogenases; Adrenocorticotropic Hormone; Androgens; Androstenedione; Aromatase; Body Weight; Breast Neoplasms; Estradiol; Estrogens; Fatty Acids, Nonesterified; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Obesity	1986
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors. Critical reviews in oncology/hematology, 1986, Volume: 5, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen	1986
Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy. Progress in clinical and biological research, 1988, Volume: 262 Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplasms, Hormone-Dependent; Pargyline; Rats	1988
Aromatase inhibitors: basic and clinical studies. Journal of steroid biochemistry, 1987, Volume: 27, Issue:4-6 Topics: Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Ovary	1987
Enzymatic control of estrogen production in human breast cancer: relative significance of aromatase versus sulfatase pathways. Annals of the New York Academy of Sciences, 1986, Volume: 464 Topics: 17-Hydroxysteroid Dehydrogenases; Adrenalectomy; Aminoglutethimide; Androstenedione; Animals; Aromatase; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Mammary Neoplasms, Experimental; Neoplasms, Hormone-Dependent; Rats; Sulfatases; Testolactone	1986
Aromatase inhibition and its pharmacologic implications. Biochemical pharmacology, 1985, Sep-15, Volume: 34, Issue:18 Topics: Androstatrienes; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Kinetics; Macaca mulatta; Male; Mammary Neoplasms, Experimental; Menopause; Oligospermia; Oxidoreductases; Rats; Uterine Neoplasms	1985

Trials

52 trial(s) available for androstenedione and Breast Neoplasms

Article	Year
Estrogens and their precursors in postmenopausal women with early breast cancer receiving anastrozole. Steroids, 2015, Volume: 99, Issue:Pt A Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Middle Aged; Nitriles; Postmenopause; Testosterone; Triazoles	2015
Effects of Pomegranate Juice on Hormonal Biomarkers of Breast Cancer Risk. Nutrition and cancer, 2015, Volume: 67, Issue:7 Topics: Androstenedione; Biomarkers, Tumor; Body Mass Index; Breast Neoplasms; Estradiol; Estrone; Female; Fruit and Vegetable Juices; Hormones; Humans; Lythraceae; Malus; Middle Aged; Postmenopause; Risk Factors; Sex Hormone-Binding Globulin; Testosterone	2015
Alberta physical activity and breast cancer prevention trial: sex hormone changes in a year-long exercise intervention among postmenopausal women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Mar-20, Volume: 28, Issue:9 Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Exercise; Female; Humans; Middle Aged; Postmenopause; Risk; Sex Hormone-Binding Globulin; Testosterone	2010
Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy. Breast cancer research and treatment, 2011, Volume: 130, Issue:2 Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Female; Humans; Letrozole; Middle Aged; Musculoskeletal Pain; Nitriles; Testosterone; Triazoles	2011
Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer. British journal of cancer, 2002, Oct-21, Volume: 87, Issue:9 Topics: Aged; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Double-Blind Method; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; Neoadjuvant Therapy; Neoplasm Staging; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Radioimmunoassay; Receptors, Estrogen; Triazoles	2002
[Clinical trial of lentaron for postmenopausal patients with advanced breast cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2002, Volume: 24, Issue:5 Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Female; Humans; Neoplasm Metastasis; Neoplasm Staging; Postmenopause; Treatment Outcome	2002
Diet and sex hormones in girls: findings from a randomized controlled clinical trial. Journal of the National Cancer Institute, 2003, Jan-15, Volume: 95, Issue:2 Topics: Adolescent; Androstenedione; Breast Neoplasms; Child; Dehydroepiandrosterone; Diet, Fat-Restricted; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Health Education; Health Promotion; Humans; Menarche; National Institutes of Health (U.S.); Progesterone; Sex Hormone-Binding Globulin; Testosterone; United States	2003
Postmenopausal women who progress on fulvestrant ('Faslodex') remain sensitive to further endocrine therapy. Breast cancer research and treatment, 2003, Volume: 79, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Double-Blind Method; Down-Regulation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Receptor Modulators; Female; Follow-Up Studies; Fulvestrant; Humans; Letrozole; Megestrol Acetate; Middle Aged; Nitriles; Postmenopause; Retrospective Studies; Salvage Therapy; Treatment Outcome; Triazoles	2003
Is there a benefit by the sequence anastrozole-formestane for postmenopausal metastatic breast cancer women? The Journal of steroid biochemistry and molecular biology, 2003, Volume: 86, Issue:1 Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Metastasis; Nitriles; Postmenopause; Receptors, Estrogen; Tamoxifen; Triazoles	2003
The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2004, Volume: 58, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrogen Antagonists; Female; Humans; Injections, Intramuscular; Middle Aged; Postmenopause; Receptors, Estradiol	2004
Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy. Steroids, 2007, Volume: 72, Issue:8 Topics: Androstenedione; Aromatase Inhibitors; Biological Assay; Breast Neoplasms; Estradiol; Female; Gas Chromatography-Mass Spectrometry; Humans; Letrozole; Nitriles; Placebos; Postmenopause; Radioimmunoassay; Sensitivity and Specificity; Tandem Mass Spectrometry; Triazoles	2007
Phase III, double-blind, controlled trial of atamestane plus toremifene compared with letrozole in postmenopausal women with advanced receptor-positive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Nov-01, Volume: 25, Issue:31 Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease Progression; Double-Blind Method; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Steroid; Toremifene; Triazoles	2007
Hydrocortisone alone vs hydrocortisone plus aminoglutethimide: a comparison of the endocrine effects in postmenopausal breast cancer. European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:4 Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Time Factors	1984
Aminoglutethimide in the treatment of advanced breast cancer. Cancer treatment reviews, 1984, Volume: 11, Issue:3 Topics: Adrenalectomy; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Glucocorticoids; Humans; Hydrocortisone; Hypophysectomy; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen	1984
The role of aromatase inhibitors in breast cancer. Seminars in oncology, 1983, Volume: 10, Issue:4 Suppl 4 Topics: Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrone; Female; Humans; Menopause; Middle Aged; Oxidoreductases; Prognosis	1983
Aromatase inhibition with 4-OHAndrostenedione after prior aromatase inhibition with aminoglutethimide in women with advanced breast cancer. Breast cancer research and treatment, 1995, Volume: 35, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasm Staging; Ovariectomy; Postmenopause	1995
The effects of oral 4-hydroxyandrostenedione on peripheral aromatisation in post-menopausal breast cancer patients. Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Postmenopause	1995
Formestane: effective therapy in postmenopausal women with advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7 Topics: 17-Hydroxycorticosteroids; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Disease-Free Survival; Estradiol; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen	1994
Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Postmenopause; Receptors, Estrogen; Survival Analysis; Tamoxifen	1994
Formestane in the treatment of advanced postmenopausal breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Injections, Intramuscular; Middle Aged; Neoplasm Metastasis; Postmenopause; Remission Induction	1994
Formestane as treatment of advanced breast cancer in elderly women. Tumori, 1994, Dec-31, Volume: 80, Issue:6 Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Prognosis; Risk Factors; Treatment Outcome	1994
Effect of two-4-hydroxyandrostenedione doses on serum insulin-like growth factor I levels in advanced breast cancer. Breast cancer research and treatment, 1994, Volume: 30, Issue:2 Topics: Aged; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Insulin-Like Growth Factor I; Middle Aged; Neoplasm Metastasis; Postmenopause; Time Factors	1994
Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer. British journal of cancer, 1994, Volume: 70, Issue:1 Topics: 17-Hydroxycorticosteroids; Aged; Analysis of Variance; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chi-Square Distribution; Estradiol; Female; Humans; Hydrocortisone; Middle Aged; Receptors, Estrogen; Remission Induction; Treatment Outcome	1994
Treatment with formestane alone and in combination with aminoglutethimide in heavily pretreated breast cancer patients: clinical and endocrine effects. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Middle Aged	1996
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Injections, Intramuscular; Middle Aged; Postmenopause; Survival Analysis; Treatment Outcome	1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK) European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:7 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cross-Over Studies; Female; Humans; Megestrol Acetate; Middle Aged; Neoplasm Metastasis; Postmenopause; Prospective Studies; Receptors, Estrogen; Regression Analysis; Remission Induction; Tamoxifen; Time Factors; Treatment Failure	1997
Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy. British journal of cancer, 1997, Volume: 76, Issue:8 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Goserelin; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Neoplasms, Hormone-Dependent; Ovariectomy; Prednisone; Preoperative Care; Tamoxifen; Treatment Outcome; Vincristine	1997
A randomised comparison of oestrogen suppression with anastrozole and formestane in postmenopausal patients with advanced breast cancer. Oncology, 1997, Volume: 54 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Female; Humans; Middle Aged; Nitriles; Postmenopause; Treatment Outcome; Triazoles	1997
In vivo inhibition of aromatization by exemestane, a novel irreversible aromatase inhibitor, in postmenopausal breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:9 Topics: Administration, Oral; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Estradiol; Estrogens; Estrone; Female; Humans; Postmenopause; Tritium	1998
In vivo measurement of aromatase inhibition by letrozole (CGS 20267) in postmenopausal patients with breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:12 Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estradiol; Estrone; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Nitriles; Postmenopause; Triazoles	1995
Profound suppression of plasma estrogens by megestrol acetate in postmenopausal breast cancer patients. Clinical cancer research : an official journal of the American Association for Cancer Research, 1996, Volume: 2, Issue:9 Topics: Administration, Oral; Aged; Androstenedione; Appetite Stimulants; Area Under Curve; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Luteinizing Hormone; Megestrol Acetate; Middle Aged; Postmenopause; Testosterone	1996
Anastrozole shows evidence of activity in postmenopausal patients who have responded or stabilised on formestane therapy. European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:5 Topics: Anastrozole; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Disease Progression; Female; Humans; Nitriles; Postmenopause; Prospective Studies; Receptors, Estrogen; Treatment Outcome; Triazoles	1999
Vorozole results in greater oestrogen suppression than formestane in postmenopausal women and when added to goserelin in premenopausal women with advanced breast cancer. Breast cancer research and treatment, 1999, Volume: 56, Issue:1 Topics: Adult; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Estradiol; Female; Goserelin; Humans; Middle Aged; Ovary; Postmenopause; Premenopause; Triazoles	1999
Quality of life in postmenopausal patients with breast cancer after failure of tamoxifen: formestane versus megestrol acetate as second-line hormonal treatment. Swiss Group for Clinical Cancer Research (SAKK). European journal of cancer (Oxford, England : 1990), 1999, Volume: 35, Issue:6 Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Megestrol Acetate; Middle Aged; Quality of Life; Tamoxifen; Treatment Failure	1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Disease-Free Survival; Female; Health Status; Humans; Megestrol Acetate; Middle Aged; Postmenopause; Quality of Life; Statistics as Topic; Treatment Outcome	1999
A randomized, open, parallel-group trial to compare the endocrine effects of oral anastrozole (Arimidex) with intramuscular formestane in postmenopausal women with advanced breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 1999, Volume: 10, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anastrozole; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Estrogens; Female; Humans; Injections, Intramuscular; Middle Aged; Nitriles; Triazoles	1999
[Sequential changes in hormone levels in postmenopausal breast cancer patients under long-term treatment with an aromatase inhibitor. Kanagawa AI Study Group]. Gan to kagaku ryoho. Cancer & chemotherapy, 1999, Volume: 26, Issue:14 Topics: Aged; Androgens; Androstenedione; Androsterone; Antineoplastic Agents, Hormonal; Breast Neoplasms; Chemotherapy, Adjuvant; Enzyme Inhibitors; Estradiol; Estrogens; Fadrozole; Female; Humans; Hydrocortisone; Middle Aged; Postmenopause; Testosterone	1999
The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers. The Journal of steroid biochemistry and molecular biology, 2000, Dec-01, Volume: 75, Issue:1 Topics: Adult; Androstenedione; Aromatase Inhibitors; Biomarkers; Bone and Bones; Breast Neoplasms; Estradiol; Female; Gonadotropin-Releasing Hormone; Growth Substances; Humans; Interleukin-6; Middle Aged; Premenopause; Statistics, Nonparametric; Triptorelin Pamoate	2000
Estrogen-receptor-directed neoadjuvant therapy for breast cancer: results of a randomised trial using formestane and methotrexate, mitozantrone and mitomycin C (MMM) chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:5 Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Goserelin; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoadjuvant Therapy; Neoplasm Metastasis; Postmenopause; Premenopause; Prognosis; Receptors, Estrogen; Survival Analysis	2001
4-hydroxyandrostenedione: a new treatment for postmenopausal patients with breast cancer. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Humans; Injections, Intramuscular; Menopause; Middle Aged; Time Factors	1992
Influence of aminoglutethimide on plasma oestrogen levels in breast cancer patients on 4-hydroxyandrostenedione treatment. Breast cancer research and treatment, 1992, Volume: 23, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Middle Aged; Pilot Projects	1992
An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28, Issue:2-3 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Female; Humans; Menopause; Middle Aged	1992
Randomised trial of chemotherapy versus endocrine therapy in patients presenting with locally advanced breast cancer (a pilot study). British journal of cancer, 1991, Volume: 63, Issue:2 Topics: Adult; Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Immunohistochemistry; Middle Aged; Neoplasm Staging; Pilot Projects; Receptors, Estrogen	1991
Primary systemic therapy for operable breast cancer. British journal of cancer, 1991, Volume: 63, Issue:4 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Combined Modality Therapy; Female; Goserelin; Humans; Lymphatic Metastasis; Middle Aged; Ovariectomy; Tamoxifen	1991
Adrenal steroids as parameters of the bioavailability of MA and MPA. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:3 Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Biological Availability; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate	1990
The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer. British journal of cancer, 1990, Volume: 62, Issue:4 Topics: Adult; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Middle Aged; Ovariectomy	1990
New trends in the endocrine treatment of breast cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen	1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Germany, West; Humans; Life Tables; Menopause; Middle Aged; Multicenter Studies as Topic; Receptors, Estrogen; Remission Induction; Tamoxifen	1990
Low dose aminoglutethimide without hydrocortisone for the treatment of advanced postmenopausal breast cancer. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Receptors, Estrogen	1989
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients. Cancer research, 1989, Mar-01, Volume: 49, Issue:5 Topics: Administration, Oral; Androstenedione; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Half-Life; Humans; Injections, Intramuscular; Menopause; Sex Hormone-Binding Globulin	1989
Aromatase in breast cancer and the role of aminoglutethimide and other aromatase inhibitors. Critical reviews in oncology/hematology, 1986, Volume: 5, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Adult; Aged; Aminoglutethimide; Androgens; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Estrogens; Female; Humans; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Middle Aged; Rats; Tamoxifen	1986
Endocrine effects of medroxyprogesterone acetate: relation between plasma levels and suppression of adrenal steroids in patients with breast cancer. Cancer treatment reports, 1985, Volume: 69, Issue:9 Topics: Adrenal Glands; Aged; Androstenedione; Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Estrone; Female; Hormones; Humans; Hydrocortisone; Medroxyprogesterone; Middle Aged; Neoplasm Metastasis; Netherlands; Random Allocation	1985

Other Studies

242 other study(ies) available for androstenedione and Breast Neoplasms

Article	Year
Sex steroid hormones and risk of breast cancer: a two-sample Mendelian randomization study. Breast cancer research : BCR, 2022, 10-08, Volume: 24, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adult; Aldosterone; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Female; Genome-Wide Association Study; Gonadal Steroid Hormones; Humans; Hydrocortisone; Longitudinal Studies; Mendelian Randomization Analysis; Progesterone; Sex Hormone-Binding Globulin; Testosterone	2022
In vitro and in vivo effect of flutamide on steroid hormone secretion in canine and human inflammatory breast cancer cell lines. Veterinary and comparative oncology, 2018, Volume: 16, Issue:1 Topics: Androstenedione; Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Dihydrotestosterone; Dog Diseases; Dogs; Estradiol; Estrone; Female; Flutamide; Gonadal Steroid Hormones; Humans; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Pregnenolone; Progesterone; Testosterone	2018
Angela M. Hartley Brodie (1934-2017). Nature, 2017, 08-02, Volume: 548, Issue:7665 Topics: Androstadienes; Androstenedione; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Estrogens; Female; History, 20th Century; History, 21st Century; Humans; Male; Maryland; Prostatic Neoplasms	2017
The beneficial androgenic action of steroidal aromatase inactivators in estrogen-dependent breast cancer after failure of nonsteroidal drugs. Cell death & disease, 2019, 06-24, Volume: 10, Issue:7 Topics: Androgens; Androstenedione; Animals; Anthracenes; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Female; Humans; Male; Mammary Neoplasms, Animal; MCF-7 Cells; Piperidines; Prostate; Protein Binding; Rats; RNA, Small Interfering; Seminal Vesicles; Steroids	2019
Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy. Molecular cancer therapeutics, 2019, Volume: 18, Issue:10 Topics: Adaptation, Physiological; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Survival; Disease-Free Survival; Drug Resistance, Neoplasm; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Phosphatidylinositol 3-Kinases; Postmenopause; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Quinolines; Receptors, Androgen; Receptors, Estrogen; RNA, Messenger; Signal Transduction; Steroids; Transcriptome; Up-Regulation	2019
Effect of selumetinib on the growth of anastrozole-resistant tumors. Breast cancer research and treatment, 2013, Volume: 138, Issue:3 Topics: Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Humans; MAP Kinase Kinase 1; Mice; Mice, Nude; Nitriles; Ovariectomy; Proto-Oncogene Proteins c-akt; TOR Serine-Threonine Kinases; Triazoles; Xenograft Model Antitumor Assays	2013
Studying the connection between exercise and cancer risk reduction. Journal of the National Cancer Institute, 2013, Jun-05, Volume: 105, Issue:11 Topics: Androstenedione; Biomarkers; Breast Neoplasms; Colonic Neoplasms; Diet, Reducing; Endometrial Neoplasms; Estrogens; Exercise; Female; Humans; Inflammation; Male; Motor Activity; Neoplasms; Obesity; Ovarian Neoplasms; Physical Exertion; Prostatic Neoplasms; Risk Assessment; Risk Factors; Risk Reduction Behavior; Sex Hormone-Binding Globulin	2013
Synthesis and bioconversions of formestane. Journal of natural products, 2013, Oct-25, Volume: 76, Issue:10 Topics: Androstenedione; Aromatase Inhibitors; Beauveria; Biotransformation; Breast Neoplasms; Female; Humans; Stereoisomerism; Testosterone	2013
AR collaborates with ERα in aromatase inhibitor-resistant breast cancer. Breast cancer research and treatment, 2014, Volume: 147, Issue:3 Topics: Anastrozole; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Antagonists; Female; Fulvestrant; Humans; MCF-7 Cells; Nitriles; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Receptors, Androgen; Tamoxifen; Triazoles	2014
QM/MM modeling of the hydroxylation of the androstenedione substrate catalyzed by cytochrome P450 aromatase (CYP19A1). Journal of computational chemistry, 2015, Sep-05, Volume: 36, Issue:23 Topics: Androstenedione; Aromatase; Breast Neoplasms; Catalytic Domain; Female; Humans; Hydroxylation; Molecular Dynamics Simulation; Oxygen; Quantum Theory; Thermodynamics	2015
Associations of sex steroid hormones with mortality in women with breast cancer. Breast cancer research and treatment, 2016, Volume: 155, Issue:3 Topics: Adult; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Neoplasm Staging; Postmenopause; Proportional Hazards Models; Sex Hormone-Binding Globulin; Testosterone	2016
Theoretical Study of the Mechanism of Exemestane Hydroxylation Catalyzed by Human Aromatase Enzyme. The journal of physical chemistry. B, 2016, Apr-07, Volume: 120, Issue:13 Topics: Androstadienes; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Hydroxylation; Molecular Docking Simulation; Thermodynamics	2016
Exploring new chemical functionalities to improve aromatase inhibition of steroids. Bioorganic & medicinal chemistry, 2016, 06-15, Volume: 24, Issue:12 Topics: Androstanes; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Molecular Docking Simulation; Steroids; Structure-Activity Relationship	2016
Synthesis and evaluation of novel 4-amino-4,6-androstadiene-3,17-dione: an analog of formestane. Bioorganic & medicinal chemistry letters, 2008, Oct-15, Volume: 18, Issue:20 Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase; Breast Neoplasms; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Humans; Models, Chemical	2008
An efficient steroid pharmacophore-based strategy to identify new aromatase inhibitors. European journal of medicinal chemistry, 2009, Volume: 44, Issue:10 Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Female; Humans; Models, Molecular; Placenta; Pregnancy; Structure-Activity Relationship	2009
Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer. The Journal of steroid biochemistry and molecular biology, 2010, Feb-15, Volume: 118, Issue:3 Topics: 20-alpha-Dihydroprogesterone; 3-Hydroxysteroid Dehydrogenases; 5-alpha-Dihydroprogesterone; Aldo-Keto Reductase Family 1 Member C3; Androstenedione; Androsterone; Biocatalysis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Dinoprost; Estradiol; Estrone; Etiocholanolone; Female; Gene Expression Regulation, Neoplastic; Gonadal Steroid Hormones; Humans; Hydroxyprostaglandin Dehydrogenases; Ketosteroids; Kinetics; Progesterone; Prostaglandin D2; Prostaglandins; Recombinant Proteins; Testosterone; Transfection; Up-Regulation	2010
Transferrin-conjugated lipid-coated PLGA nanoparticles for targeted delivery of aromatase inhibitor 7alpha-APTADD to breast cancer cells. International journal of pharmaceutics, 2010, May-10, Volume: 390, Issue:2 Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Female; Humans; Lactic Acid; Nanoparticles; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Static Electricity; Transferrin	2010
Combined inhibitory effect of formestane and herceptin on a subpopulation of CD44+/CD24low breast cancer cells. Cancer science, 2010, Volume: 101, Issue:7 Topics: Androstenedione; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Breast Neoplasms; CD24 Antigen; Cell Line, Tumor; DNA Primers; ErbB Receptors; Female; Humans; Hyaluronan Receptors; Receptor Cross-Talk; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Trastuzumab; Tumor Cells, Cultured	2010
Molecular docking and QSAR studies of aromatase inhibitor androstenedione derivatives. The Journal of pharmacy and pharmacology, 2010, Volume: 62, Issue:12 Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Catalytic Domain; Chemical Phenomena; Estrogens; Female; Humans; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Neoplasms, Hormone-Dependent; Quantitative Structure-Activity Relationship	2010
Binding features of steroidal and nonsteroidal inhibitors. Steroids, 2011, Volume: 76, Issue:8 Topics: Amino Acids; Androgens; Androstadienes; Androstenedione; Aromatase; Aromatase Inhibitors; Binding Sites; Breast Neoplasms; Catalytic Domain; Estrogens; Estrone; Female; Humans; Letrozole; Mutagenesis, Site-Directed; NADPH-Ferrihemoprotein Reductase; Neoplasms, Hormone-Dependent; Nitriles; Protein Conformation; Structure-Activity Relationship; Triazoles	2011
Breast ductal lavage for assessment of breast cancer biomarkers. Hormones & cancer, 2010, Volume: 1, Issue:4 Topics: Adult; Aged; Analysis of Variance; Androstenedione; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Breast; Breast Neoplasms; Cathepsin D; Dehydroepiandrosterone; Epidermal Growth Factor; Estradiol; Estrone; Female; Humans; Immunoassay; Middle Aged; Postmenopause; Premenopause; Progesterone; Tamoxifen; Therapeutic Irrigation	2010
Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol. Cancer science, 2011, Volume: 102, Issue:10 Topics: Adult; Androstenediol; Androstenedione; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Dehydroepiandrosterone; Estradiol; Estrogen Receptor alpha; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Postmenopause; Premenopause	2011
Sex steroid hormone levels in breast adipose tissue and serum in postmenopausal women. Breast cancer research and treatment, 2012, Volume: 131, Issue:1 Topics: Adipose Tissue; Adult; Aged; Androstenedione; Body Mass Index; Breast Neoplasms; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Postmenopause; Receptors, Estrogen; Receptors, Progesterone; Sex Hormone-Binding Globulin; Testosterone	2012
Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women. Endocrine-related cancer, 2012, Volume: 19, Issue:2 Topics: Aged; Androstenedione; Breast Neoplasms; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrone; Female; Gonadal Steroid Hormones; Humans; Immunoassay; Middle Aged; Postmenopause; Receptors, Androgen; Risk Assessment; Sex Hormone-Binding Globulin; Testosterone	2012
Premenopausal serum androgens and breast cancer risk: a nested case-control study. Breast cancer research : BCR, 2012, Feb-16, Volume: 14, Issue:1 Topics: Adult; Aged; Androgens; Androstenedione; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Case-Control Studies; Dehydroepiandrosterone Sulfate; Female; Humans; Logistic Models; Middle Aged; Odds Ratio; Premenopause; Risk Factors; Sex Hormone-Binding Globulin; Testosterone	2012
AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research, 2012, Jun-15, Volume: 18, Issue:12 Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Disease-Free Survival; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Humans; JNK Mitogen-Activated Protein Kinases; Letrozole; MAP Kinase Signaling System; Neoplasm Recurrence, Local; Nitriles; Nuclear Receptor Coactivator 3; Promoter Regions, Genetic; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Trefoil Factor-1; Triazoles; Tumor Suppressor Proteins; Up-Regulation	2012
ANN-QSAR model for virtual screening of androstenedione C-skeleton containing phytomolecules and analogues for cytotoxic activity against human breast cancer cell line MCF-7. Combinatorial chemistry & high throughput screening, 2013, Volume: 16, Issue:1 Topics: Androstenedione; Antineoplastic Agents; Aromatase; Breast; Breast Neoplasms; Cell Survival; Computer Simulation; Drug Discovery; Female; Humans; MCF-7 Cells; Models, Biological; Molecular Docking Simulation; Neural Networks, Computer; Protein Binding; Quantitative Structure-Activity Relationship	2013
Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells. Oncogene, 2013, Oct-31, Volume: 32, Issue:44 Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Biomarkers, Tumor; Breast Neoplasms; CD24 Antigen; Cell Line; Cell Movement; Cell Proliferation; Cell Transformation, Neoplastic; Estradiol; Estrogen Receptor alpha; Female; Gene Expression; Humans; Hyaluronan Receptors; Letrozole; Neoplastic Stem Cells; Nitriles; RNA, Messenger; Spheroids, Cellular; Triazoles	2013
Alcohol and breast cancer risk among Asian-American women in Los Angeles County. Breast cancer research : BCR, 2012, Nov-27, Volume: 14, Issue:6 Topics: Adult; Aged; Alcohol Drinking; Androgens; Androstenedione; Asian; Breast Neoplasms; Case-Control Studies; Cohort Studies; Dehydroepiandrosterone Sulfate; Estrone; Female; Humans; Insulin-Like Growth Factor Binding Protein 3; Los Angeles; Middle Aged; Risk; Testosterone	2012
Aromatase overexpression enhances the stimulatory effects of adrenal androgens on MCF7 breast cancer cells. Molecular and cellular endocrinology, 2002, Jul-31, Volume: 193, Issue:1-2 Topics: Adrenal Glands; Androgens; Androstenediol; Androstenedione; Aromatase; Breast Neoplasms; Cell Division; Dehydroepiandrosterone; Estrogen Receptor alpha; Female; Gene Expression Regulation; Humans; Receptors, Estrogen; Transfection; Tumor Cells, Cultured	2002
Effect of antiestrogens and aromatase inhibitor on basal growth of the human breast cancer cell line MCF-7 in serum-free medium. The Journal of steroid biochemistry and molecular biology, 2003, Volume: 84, Issue:4 Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Blotting, Northern; Blotting, Western; Breast Neoplasms; Cell Division; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; Humans; Ligands; Membrane Proteins; Piperidines; Presenilin-2; Protein Binding; Receptors, Estrogen; RNA, Messenger; Tamoxifen; Time Factors; Tumor Cells, Cultured	2003
Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line. The Journal of biological chemistry, 2003, Aug-01, Volume: 278, Issue:31 Topics: Androstenedione; Aromatase; Breast Neoplasms; Cell Division; DNA; DNA-Binding Proteins; Estradiol; Estrogen Receptor alpha; Gene Expression Regulation, Enzymologic; Humans; Leptin; Luciferases; Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Receptors, Estrogen; Recombinant Fusion Proteins; RNA, Messenger; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured	2003
[ON THE APPEARANCE OF DELTA-4-ANDROSTENE-3,17-DIONE AND TESTOSTERONE IN THE URINE AFTER INFUSION OF DELTA-5-ANDROSTENE-3-BETA-OL-17-ONE PHOSPHATE]. Hoppe-Seyler's Zeitschrift fur physiologische Chemie, 1964, Volume: 336 Topics: Androstenedione; Breast Neoplasms; Cyclosporins; Humans; Injections, Intravenous; Phosphates; Steroids; Testosterone; Urine	1964
[METABOLISM AND METABOLIC REACTIONS AFTER INFUSION OF DEHYDROEPIANDROSTERONE PHOSPHATE IN BREAST CANCER AND MASTOPATHY. II. THE FORMATION OF DELTA-4-ANDROSTENE-3,17-DIONE, TESTOSTERONE AND 7-KETO-DEHYDROEPIANDROSTERONE]. Archiv fur Geschwulstforschung, 1964, Volume: 24 Topics: Androgens; Androstenedione; Androstenes; Breast Diseases; Breast Neoplasms; Dehydroepiandrosterone; Humans; Metabolism; Phosphates; Testosterone	1964
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Cancer causes & control : CCC, 2003, Volume: 14, Issue:7 Topics: Androstenedione; Breast Neoplasms; Case-Control Studies; Dehydroepiandrosterone; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Logistic Models; Middle Aged; Prolactin; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Sweden; Testosterone	2003
Serum adrenal androgens in women with primary operable breast cancer and their relationship with age and body mass index. Breast (Edinburgh, Scotland), 2003, Volume: 12, Issue:1 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Androstenedione; Body Mass Index; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Female; Humans; Middle Aged; Postmenopause; Premenopause	2003
Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Cancer causes & control : CCC, 2004, Volume: 15, Issue:1 Topics: Adult; Androstenedione; Breast Neoplasms; Case-Control Studies; Dehydroepiandrosterone; Estradiol; Female; Gonadal Steroid Hormones; Humans; Premenopause; Progesterone; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Surveys and Questionnaires; Testosterone	2004
Breast cancer size in postmenopausal women is correlated with body mass index and androgen serum levels. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2004, Volume: 18, Issue:1 Topics: Adult; Androstenedione; Body Mass Index; Breast Neoplasms; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Leptin; Menopause; Middle Aged; Testosterone	2004
Epidemiology of urinary melatonin in women and its relation to other hormones and night work. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:6 Topics: Adult; Androstenedione; Androstenols; Biological Availability; Biomarkers; Body Mass Index; Breast Neoplasms; Cohort Studies; Creatinine; Dehydroepiandrosterone; Estradiol; Estrone; Female; Hormones; Humans; Light; Melatonin; Middle Aged; Nurses; Prolactin; Reproducibility of Results; Risk Factors; Specimen Handling; Steroids; Work Schedule Tolerance	2004
Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Journal of the National Cancer Institute, 2004, Jun-16, Volume: 96, Issue:12 Topics: 17-alpha-Hydroxyprogesterone; Aged; Androstenedione; Aromatase; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Case-Control Studies; Catechol O-Methyltransferase; Cytochrome P-450 CYP1B1; England; Estradiol; Estrone; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Gonadal Steroid Hormones; Humans; Linear Models; Middle Aged; Odds Ratio; Polymorphism, Single Nucleotide; Postmenopause; Sex Hormone-Binding Globulin; Steroid 17-alpha-Hydroxylase; Testosterone	2004
Partial agonist/antagonist properties of androstenedione and 4-androsten-3beta,17beta-diol. The Journal of steroid biochemistry and molecular biology, 2004, Volume: 91, Issue:4-5 Topics: Adaptor Proteins, Signal Transducing; Androgen Antagonists; Androgen Receptor Antagonists; Androgens; Androstenediol; Androstenedione; Anilides; Animals; Breast Neoplasms; Carrier Proteins; Cell Division; Chlorocebus aethiops; COS Cells; Cyproterone Acetate; Dihydrotestosterone; Humans; Ligands; Macaca mulatta; Male; Mammary Tumor Virus, Mouse; Mice; Nerve Tissue Proteins; Nitriles; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, AMPA; Receptors, Androgen; Tosyl Compounds; Transcription, Genetic; Tumor Cells, Cultured	2004
Alcohol and endogenous sex steroid levels in postmenopausal women: a cross-sectional study. The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:3 Topics: Aged; Alcohol Drinking; Androstenedione; Breast Neoplasms; Cross-Sectional Studies; Dehydroepiandrosterone; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Postmenopause; Risk Factors; Sex Hormone-Binding Globulin; Testosterone	2005
Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Journal of the National Cancer Institute, 2004, Dec-15, Volume: 96, Issue:24 Topics: Aged; Androgens; Androstenedione; Breast Neoplasms; Case-Control Studies; Confidence Intervals; Dehydroepiandrosterone; Estradiol; Estrogens; Estrone; Female; Humans; Middle Aged; Postmenopause; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Risk Assessment; Risk Factors; Testosterone	2004
Melatonin modulates aromatase activity in MCF-7 human breast cancer cells. Journal of pineal research, 2005, Volume: 38, Issue:2 Topics: Androgens; Androstenedione; Antineoplastic Agents; Aromatase; Breast Neoplasms; Cell Proliferation; Female; Humans; Melatonin; RNA, Messenger; Testosterone; Tritium	2005
Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line. The Journal of steroid biochemistry and molecular biology, 2005, Volume: 93, Issue:1 Topics: Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Culture Media; Dose-Response Relationship, Drug; Estrogen Antagonists; Estrogens; Estrone; Female; Humans; Letrozole; Nitriles; Receptors, Estrogen; Testosterone; Triazoles; Tumor Cells, Cultured	2005
Aromatase inhibitors increase the sensitivity of human tumor cells to monocyte-mediated, antibody-dependent cellular cytotoxicity. American journal of surgery, 2005, Volume: 190, Issue:4 Topics: Androstenedione; Antibody-Dependent Cell Cytotoxicity; Aromatase Inhibitors; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Female; Humans; Monocytes; Mucin-1; Ovarian Neoplasms; Peptide Elongation Factor 1; Receptors, Estrogen	2005
Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients. The Journal of steroid biochemistry and molecular biology, 2005, Volume: 96, Issue:5 Topics: Aged; Aged, 80 and over; Androgens; Androstenedione; Breast Neoplasms; Diethylstilbestrol; Drug Administration Schedule; Estradiol; Estrogens; Estrogens, Non-Steroidal; Estrone; Female; Humans; Hydrocortisone; Middle Aged; Postmenopause; Sex Hormone-Binding Globulin	2005
ErbB receptor signaling and therapeutic resistance to aromatase inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Feb-01, Volume: 12, Issue:3 Pt 2 Topics: Acetyltransferases; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Corticosterone; Drug Resistance, Neoplasm; Female; Histone Acetyltransferases; Humans; Letrozole; Nitriles; Nuclear Receptor Coactivator 3; Oncogene Proteins; Promoter Regions, Genetic; Receptor, ErbB-2; Receptors, Estrogen; Signal Transduction; Trans-Activators; Transcriptional Activation; Triazoles	2006
Microbial metabolism of methyl protodioscin by Aspergillus niger culture--a new androstenedione producing way from steroid. The Journal of steroid biochemistry and molecular biology, 2006, Volume: 100, Issue:1-3 Topics: Adenocarcinoma; Androstenedione; Aspergillus niger; Biotransformation; Breast Neoplasms; Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Diosgenin; Dose-Response Relationship, Drug; Female; HeLa Cells; Humans; Inhibitory Concentration 50; Liver Neoplasms; Lung Neoplasms; Molecular Structure; Saponins; Steroids; Uterine Cervical Neoplasms	2006
Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole. Cancer research, 2006, Aug-01, Volume: 66, Issue:15 Topics: Androgen Receptor Antagonists; Androgens; Androstenedione; Aromatase; Breast Neoplasms; Cell Growth Processes; Cell Line, Tumor; Dihydrotestosterone; Estradiol; Estrogen Receptor alpha; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Proto-Oncogene Proteins c-bcl-2; Receptors, Androgen; RNA, Small Interfering; Transfection; Triazoles	2006
Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells. Prostaglandins & other lipid mediators, 2006, Volume: 81, Issue:1-2 Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Estradiol; Female; Gene Expression Regulation, Enzymologic; Humans; Promoter Regions, Genetic; Pyrazoles; Sulfonamides	2006
Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern. The Journal of endocrinology, 2006, Volume: 190, Issue:3 Topics: Analysis of Variance; Androgens; Androstane-3,17-diol; Androstenedione; Breast Neoplasms; Carbon Isotopes; Cell Line, Tumor; Dose-Response Relationship, Drug; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Gene Expression Profiling; HeLa Cells; Humans; Isotope Labeling; Testosterone; Transcriptional Activation; Transfection	2006
Alcohol and dietary fibre intakes affect circulating sex hormones among premenopausal women. Public health nutrition, 2006, Volume: 9, Issue:7 Topics: Adolescent; Adult; Alcohol Drinking; Androgens; Androstenedione; Breast Neoplasms; Diet Surveys; Dietary Fiber; Edible Grain; Estradiol; Estrogens; Female; Fruit; Gonadal Steroid Hormones; Humans; Premenopause; Progesterone; Risk Factors; Sex Hormone-Binding Globulin; Surveys and Questionnaires; Vegetables	2006
Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2006, Volume: 15, Issue:10 Topics: Aged; Aged, 80 and over; Androgens; Androstenedione; Asian; Black or African American; Breast Neoplasms; California; Case-Control Studies; Cross-Sectional Studies; Estradiol; Estrogens; Estrone; Female; Hawaii; Hispanic or Latino; Humans; Incidence; Middle Aged; Multivariate Analysis; Postmenopause; Prospective Studies; Risk Factors; SEER Program; Sex Hormone-Binding Globulin; Testosterone; White People	2006
Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels. The Journal of steroid biochemistry and molecular biology, 2007, Volume: 104, Issue:1-2 Topics: Aged; Androstenedione; Aromatase; Aromatase Inhibitors; Body Mass Index; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Leptin; Middle Aged; Postmenopause	2007
Coadministration of the aromatase inhibitor formestane and an isopropanolic extract of black cohosh in a rat model of chemically induced mammary carcinoma. Planta medica, 2007, Volume: 73, Issue:4 Topics: 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Antineoplastic Agents, Phytogenic; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Cimicifuga; Drug Therapy, Combination; Estradiol; Female; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley	2007
Inhibition of the phosphatidylinositol 3-kinase/Akt pathway improves response of long-term estrogen-deprived breast cancer xenografts to antiestrogens. Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, May-01, Volume: 13, Issue:9 Topics: Androstadienes; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Estrogen Receptor alpha; Estrogen Receptor Modulators; Humans; Letrozole; Mice; Mice, Nude; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Tamoxifen; Triazoles; Wortmannin	2007
Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. International journal of cancer, 2007, Dec-01, Volume: 121, Issue:11 Topics: Aged; Androstenedione; Breast; Breast Neoplasms; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor I; Mammography; Middle Aged; Norway; Postmenopause; Prolactin; Risk Factors; Sex Hormone-Binding Globulin; Testosterone	2007
Preeclampsia and maternal breast cancer risk by offspring gender: do elevated androgen concentrations play a role? British journal of cancer, 2007, Sep-03, Volume: 97, Issue:5 Topics: Androgens; Androstenedione; Breast Neoplasms; Case-Control Studies; Female; Humans; Infant, Newborn; Logistic Models; Male; New York; Odds Ratio; Pennsylvania; Pre-Eclampsia; Pregnancy; Radioimmunoassay; Risk Factors; Sex Factors	2007
Toremifene-atamestane; alone or in combination: predictions from the preclinical intratumoral aromatase model. The Journal of steroid biochemistry and molecular biology, 2008, Volume: 108, Issue:1-2 Topics: Androstenedione; Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Breast Neoplasms; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Mice; Mice, SCID; Prognosis; Toremifene; Transfection; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2008
In vitro expansion of human breast cancer epithelial and mesenchymal stromal cells: optimization of a coculture model for personalized therapy approaches. Molecular cancer therapeutics, 2007, Volume: 6, Issue:12 Pt 1 Topics: Androstenedione; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aromatase; Aromatase Inhibitors; Base Sequence; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Coculture Techniques; Cryopreservation; DNA Primers; Epithelial Cells; Humans; Mesoderm; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stromal Cells; Trastuzumab	2007
4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer. Lancet (London, England), 1984, Dec-01, Volume: 2, Issue:8414 Topics: Adult; Aged; Androstenedione; Animals; Bone Neoplasms; Breast Neoplasms; Castration; Estradiol; Female; Humans; Injections, Intramuscular; Menopause; Mice; Middle Aged	1984
The metabolism of androstenedione and testosterone to C19 metabolites in normal breast, breast carcinoma and benign prostatic hypertrophy tissue. Journal of steroid biochemistry, 1983, Volume: 19, Issue:2 Topics: Androstenedione; Androsterone; Breast; Breast Neoplasms; Dihydrotestosterone; Etiocholanolone; Female; Humans; Male; Prostatic Hyperplasia; Testosterone	1983
Comparative studies of aromatase inhibitors in relation to the significance of estrogen synthesis in human mammary tumors. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Aminoglutethimide; Androgens; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cyanoketone; Dehydroepiandrosterone; Estrogens; Female; Humans; Kinetics; Oxidoreductases; Receptors, Estrogen	1982
Endocrine and therapeutic effects of aminoglutethimide in premenopausal patients with breast cancer. The Journal of clinical endocrinology and metabolism, 1982, Volume: 55, Issue:4 Topics: Adult; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Therapy, Combination; Estradiol; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Menstruation; Middle Aged	1982
Role of human adipose tissue in the production and metabolism of steroid hormones. Endokrinologie, 1982, Volume: 80, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adipose Tissue; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estrogens; Female; Gonadal Steroid Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Male; Obesity; Progesterone; Radioimmunoassay; Testosterone	1982
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. British journal of cancer, 1983, Volume: 47, Issue:5 Topics: 17-alpha-Hydroxyprogesterone; Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cosyntropin; Dehydroepiandrosterone; Drug Administration Schedule; Drug Therapy, Combination; Estrone; Female; Hormones; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged	1983
Endocrine changes associated with relapse in advanced breast cancer patients on aminoglutethimide therapy. The Journal of clinical endocrinology and metabolism, 1984, Volume: 58, Issue:1 Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Hormones; Humans; Hydrocortisone; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Prolactin	1984
Conjugation of androgens and estrogens by human breast tumors in vitro. Steroids, 1980, Volume: 35, Issue:6 Topics: Adult; Aged; Androgens; Androstane-3,17-diol; Androstenedione; Androsterone; Breast Neoplasms; Carcinoma; Carcinoma, Intraductal, Noninfiltrating; Estriol; Estrogens; Female; Humans; Middle Aged; Receptors, Estrogen; Testosterone	1980
Adrenal suppression by oral high-dose medroxyprogesterone acetate in breast cancer patients. Cancer chemotherapy and pharmacology, 1984, Volume: 12, Issue:2 Topics: Adrenocorticotropic Hormone; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Pituitary Hormones	1984
17 Beta-hydroxysteroid dehydrogenase and aromatase activity in breast fat from women with benign and malignant breast tumours. Clinical endocrinology, 1984, Volume: 20, Issue:2 Topics: 17-Hydroxysteroid Dehydrogenases; Adipose Tissue; Adult; Age Factors; Aged; Androstenedione; Aromatase; Body Weight; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Middle Aged; Oxidoreductases	1984
Potency of the effect of D-stereoisomer of aminoglutethimide on adrenal and extraadrenal steroidogenesis. The Journal of clinical endocrinology and metabolism, 1980, Volume: 51, Issue:3 Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Stereoisomerism	1980
Hormone synthesis by primary breast carcinomas and prognosis in human breast cancer. Tumori, 1980, Apr-30, Volume: 66, Issue:2 Topics: Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Neoplasm Staging; Pregnenolone; Progesterone; Prognosis; Recurrence	1980
Effects of adjuvant chemohormonal therapy on the ovarian and adrenal function of breast cancer patients. Cancer research, 1980, Volume: 40, Issue:11 Topics: Adrenal Cortex; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menstruation; Ovary; Prednisone; Sex Hormone-Binding Globulin; Tamoxifen	1980
How effective is surgical adrenalectomy in lowering steroid hormone concentrations? The Journal of clinical endocrinology and metabolism, 1982, Volume: 54, Issue:1 Topics: Adrenalectomy; Aged; Aldosterone; Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged	1982
[Steroid hormone content of the breast tissue in breast tumors]. Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 1982, Volume: 53, Issue:1 Topics: Adolescent; Adult; Aged; Androstenedione; Breast; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Hydroxyprogesterones; Middle Aged; Progesterone; Radioimmunoassay; Testosterone	1982
Serum prolactin, androgens, oestradiol and progesterone in adolescent girls with or without a family history of breast cancer. European journal of cancer & clinical oncology, 1981, Volume: 17, Issue:10 Topics: Adolescent; Adult; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Menstruation; Progesterone; Prolactin	1981
Biological significance of aromatase activity in human breast tumors. The Journal of clinical endocrinology and metabolism, 1983, Volume: 57, Issue:6 Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrone; Female; Humans; Oxidoreductases; Receptors, Estrogen; Receptors, Progesterone; Testolactone	1983
The intracellular control of aromatase activity by 5 alpha-reduced androgens in human breast carcinoma cells in culture. The Journal of clinical endocrinology and metabolism, 1984, Volume: 58, Issue:3 Topics: Androstenedione; Aromatase; Breast Neoplasms; Cell Line; Estrone; Feedback; Female; Humans; Oxidation-Reduction; Oxidoreductases; Testosterone	1984
Overview of recent development of aromatase inhibitors. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Aminoglutethimide; Androstatrienes; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; In Vitro Techniques; Macaca mulatta; Male; Oxidoreductases; Pregnancy; Rats	1982
A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Androstadienes; Androstatrienes; Androstenedione; Androstenes; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy; Structure-Activity Relationship; Testolactone	1982
Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Adrenalectomy; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Castration; Estrogens; Female; Humans; Kinetics; Neoplasm Recurrence, Local; Oxidoreductases; Receptors, Estrogen; Testolactone	1982
Aromatase in human breast carcinoma. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Adipose Tissue; Androgens; Androstenedione; Aromatase; Breast Neoplasms; Cells, Cultured; Estrogens; Estrone; Female; Humans; Oxidoreductases; Testosterone	1982
Comparative studies of aromatase inhibitors in cultured human breast cancer cells. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line; Dihydrotestosterone; Estradiol; Female; Humans; Oxidoreductases; Pargyline; Receptors, Estrogen; Receptors, Progesterone; Testolactone; Testosterone	1982
In vivo effects of delta 1-testololactone on peripheral aromatization. Cancer research, 1982, Volume: 42, Issue:8 Suppl Topics: Aged; Androstenedione; Aromatase; Breast Neoplasms; Dexamethasone; Dose-Response Relationship, Drug; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Oxidoreductases; Testolactone; Testosterone	1982
Steroid metabolism and oestrogen receptors in human breast carcinomas. European journal of cancer & clinical oncology, 1981, Volume: 17, Issue:8 Topics: Androstane-3,17-diol; Androstenedione; Breast Neoplasms; Dihydrotestosterone; Estradiol; Female; Humans; Menopause; Receptors, Estrogen; Testosterone	1981
Androgen metabolism in male and female breast tissue. Steroids, 1981, Volume: 37, Issue:3 Topics: Adolescent; Adult; Aged; Androstenedione; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Fibrocystic Breast Disease; Gynecomastia; Humans; Male; Middle Aged; Sex Factors; Testosterone	1981
Plasma concentration gradient of steroid hormones across human mammary tumours in vivo. Journal of steroid biochemistry, 1981, Volume: 14, Issue:8 Topics: Adult; Androgens; Androstenedione; Arteries; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Middle Aged; Testosterone; Veins	1981
Effects of 4-hydroxy-4-androstene-3, 17-dione and 10-propargylestr-4-ene-3, 17-dione on the metabolism of androstenedione in human breast carcinoma and breast adipose tissues. Steroids, 1981, Volume: 38, Issue:4 Topics: Adipose Tissue; Androstenedione; Breast; Breast Neoplasms; Female; Humans; Kinetics; Pargyline	1981
Studies of oestrogen metabolism in postmenopausal women with cancer. Journal of steroid biochemistry, 1981, Volume: 15 Topics: Adipose Tissue; Aged; Androstenedione; Body Weight; Breast Neoplasms; Endometrial Hyperplasia; Estradiol; Estrogens; Estrone; Female; Humans; In Vitro Techniques; Menopause; Middle Aged; Uterine Neoplasms	1981
Medical adrenalectomy may replace surgery for advanced breast cancer. JAMA, 1980, Jul-04, Volume: 244, Issue:1 Topics: Adipose Tissue; Adrenal Glands; Adrenalectomy; Aminoglutethimide; Androstenedione; Breast Neoplasms; Cholesterol; Estradiol; Estrogen Antagonists; Female; Humans; Pregnenolone	1980
The conversion of androstenedione to estrone, estradiol, and testosterone in breast tissue. Journal of steroid biochemistry, 1980, Volume: 13, Issue:1 Topics: Adipose Tissue; Adult; Aged; Androstenedione; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Male; Middle Aged; Testosterone	1980
Inhibition of estrogen synthesis in human breast tumors by testololactone and bromoandrostenedione. Steroids, 1980, Volume: 35, Issue:5 Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Kinetics; Steroids, Heterocyclic; Testolactone	1980
Inhibition of androgen aromatization in human breast cancer. Journal of steroid biochemistry, 1980, Volume: 13, Issue:12 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Estradiol; Estrone; Female; Humans; Kinetics; Microsomes; Oxidoreductases; Placenta; Pregnancy	1980
Progress in the treatment and palliation of advanced breast cancer. Symposium proceedings. Jerusalem, 1993. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7 Topics: Androstenedione; Animals; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Palliative Care; Pamidronate	1994
Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients. Clinical endocrinology, 1995, Volume: 42, Issue:1 Topics: Aged; Androstenedione; Breast Neoplasms; Carrier Proteins; Estradiol; Estrogens; Estrone; Female; Gonadal Steroid Hormones; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Middle Aged; Postmenopause; Sex Hormone-Binding Globulin; Testosterone; Time Factors	1995
Pseudoaromatase in circulating lymphocytes. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6 Topics: Androstenedione; Aromatase; Breast Neoplasms; Cytochrome P-450 Enzyme System; Female; Humans; Lymphocytes; Oxidoreductases; Polymerase Chain Reaction; RNA; RNA, Neoplasm	1993
Formestane: an effective first-line endocrine treatment for advanced breast cancer. Journal of cancer research and clinical oncology, 1995, Volume: 121, Issue:6 Topics: 17-Hydroxycorticosteroids; Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Administration Schedule; Estradiol; Female; Humans; Injections, Intramuscular; Middle Aged; Postmenopause; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome	1995
Treatment of advanced breast cancer with formestane. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Remission Induction; Survival Analysis	1994
Aromatase inhibition: basic concepts, and the pharmacodynamics of formestane. Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 7 Topics: Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Postmenopause	1994
Analysis of the aromatase cytochrome P450 gene in human breast cancers. Journal of molecular endocrinology, 1994, Volume: 13, Issue:3 Topics: Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cloning, Molecular; DNA Mutational Analysis; DNA Probes; Estradiol; Exons; Female; Humans; In Vitro Techniques; Molecular Sequence Data; Placenta; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational	1994
Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha. Molecular and cellular endocrinology, 1994, Volume: 106, Issue:1-2 Topics: Androstenedione; Aromatase; Breast; Breast Neoplasms; Culture Media, Conditioned; Cytosol; Dexamethasone; Estrone; Female; Fetal Blood; Fibroblasts; Fibrocystic Breast Disease; Humans; Interleukin-1; Interleukin-6; Premenopause; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1994
Steroid gradients across the cancerous breast: an index of altered steroid metabolism in breast cancer? The Journal of steroid biochemistry and molecular biology, 1994, Volume: 51, Issue:3-4 Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Prolactin; Steroids; Testosterone; Tissue Distribution	1994
A prospective study of endogenous hormones and breast cancer. Cancer detection and prevention, 1994, Volume: 18, Issue:2 Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Case-Control Studies; Cohort Studies; Educational Status; Estrogens; Female; Humans; Incidence; Maryland; Menopause; Middle Aged; Progesterone; Prolactin; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Smoking	1994
The relation of reported alcohol ingestion to plasma levels of estrogens and androgens in premenopausal women (Maryland, United States). Cancer causes & control : CCC, 1994, Volume: 5, Issue:1 Topics: Adult; Alcohol Drinking; Androgens; Androstenedione; Body Mass Index; Body Weight; Breast Neoplasms; Cross-Sectional Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Energy Intake; Estrogens; Estrone; Ethanol; Female; Food; Humans; Maryland; Menstrual Cycle; Premenopause; Progesterone; Risk Factors; Sex Hormone-Binding Globulin	1994
Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione. British journal of cancer, 1993, Volume: 68, Issue:2 Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; Male; Menopause; Middle Aged	1993
Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression. British journal of cancer, 1994, Volume: 69, Issue:6 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Carbon Radioisotopes; Estrogens; Female; Humans; Middle Aged; Postmenopause; Radioisotope Dilution Technique	1994
Effects of adrenocorticotropin on adrenal and plasma 11 beta-hydroxyandrostenedione in the guinea pig and determination of its relative androgen potency. Steroids, 1993, Volume: 58, Issue:1 Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenocorticotropic Hormone; Androstenedione; Animals; Breast Neoplasms; Cell Division; Corticosterone; Guinea Pigs; Humans; Hydrocortisone; Kinetics; Male; Orchiectomy; Organ Size; Prostate; Tumor Cells, Cultured	1993
Effect of androstenedione on growth of untransfected and aromatase-transfected MCF-7 cells in culture. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6 Topics: Analysis of Variance; Androstenedione; Aromatase; Breast Neoplasms; Cell Division; Estradiol; Female; Humans; Kinetics; Plasmids; Recombinant Proteins; RNA, Messenger; Transfection; Tumor Cells, Cultured	1993
Growth suppression of MCF-7 human breast cancer cells by aromatase inhibitors: a new system for aromatase inhibitor screening. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6 Topics: Aminoglutethimide; Androstenedione; Androstenols; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Dose-Response Relationship, Drug; Fadrozole; Female; Humans; Kinetics; Tumor Cells, Cultured	1993
MCF-7 human breast carcinomas in nude mice as a model for evaluating aromatase inhibitors. The Journal of steroid biochemistry and molecular biology, 1993, Volume: 44, Issue:4-6 Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Female; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tamoxifen; Transplantation, Heterologous; Tumor Cells, Cultured	1993
Efficacy and tolerability of 4-hydroxyandrostenedione (4-OHA) as first-line treatment in postmenopausal patients with breast cancer after adjuvant therapy. Cancer treatment reviews, 1993, Volume: 19 Suppl B Topics: Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Menopause; Methotrexate; Middle Aged; Remission Induction; Tamoxifen; Treatment Outcome	1993
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. b). Renin. European journal of gynaecological oncology, 1993, Volume: 14, Issue:2 Topics: Adipose Tissue; Androstenedione; Blood Pressure; Breast Neoplasms; Dehydroepiandrosterone; Endometrial Neoplasms; Female; Humans; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Renin; Sex Hormone-Binding Globulin; Testosterone	1993
The role of insulin and renin in the pathogenesis of hormone-dependent neoplasias. a). Insulin. European journal of gynaecological oncology, 1993, Volume: 14, Issue:2 Topics: Androstenedione; Blood Glucose; Body Weight; Breast Neoplasms; Dehydroepiandrosterone; Endometrial Neoplasms; Female; Glucose Tolerance Test; Humans; Insulin; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Sex Hormone-Binding Globulin; Testosterone	1993
A sensitive assay for measurement of plasma estrone sulphate in patients on treatment with aromatase inhibitors. The Journal of steroid biochemistry and molecular biology, 1995, Volume: 55, Issue:3-4 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrone; Female; Humans; Hydrolysis; Menopause; Radioimmunoassay; Sensitivity and Specificity	1995
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer. British journal of cancer, 1996, Volume: 73, Issue:6 Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Goserelin; Humans; Immunohistochemistry; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasms, Hormone-Dependent; Receptors, Estrogen	1996
Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology (Cambridge, Mass.), 1996, Volume: 7, Issue:1 Topics: Aged; Androstenedione; Body Mass Index; Breast Neoplasms; Case-Control Studies; Estrone; Female; Humans; Logistic Models; Odds Ratio; Postmenopause; Postoperative Period; Sex Hormone-Binding Globulin; Sweden; Testosterone	1996
Breast cancer prevention in African-American women. Journal of the National Cancer Institute, 1996, Oct-02, Volume: 88, Issue:19 Topics: Androstenedione; Black People; Breast Neoplasms; Dietary Fats; Estrogens; Female; Humans; Obesity; Risk; Risk Factors; United States; White People	1996
Oestrogen formation in breast: clinical and biological importance. The Journal of endocrinology, 1996, Volume: 150 Suppl Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast; Breast Neoplasms; Estrogens; Female; Humans; Letrozole; Mice; Mice, Nude; Nitriles; Signal Transduction; Transfection; Triazoles; Tumor Cells, Cultured	1996
Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer. The Journal of clinical endocrinology and metabolism, 1996, Volume: 81, Issue:6 Topics: Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Blotting, Western; Breast Neoplasms; Endopeptidases; Female; Humans; Insulin-Like Growth Factor Binding Proteins; Megestrol Acetate; Middle Aged; Radioimmunoassay; Somatomedins	1996
Optimization of a classical aromatase activity assay and application in normal, adenomatous and malignant breast parenchyma. The Journal of steroid biochemistry and molecular biology, 1996, Volume: 59, Issue:3-4 Topics: Adenoma; Androstenedione; Aromatase; Breast; Breast Neoplasms; Carcinoma; Estradiol; Estrone; Female; Humans; Kinetics; NADP; Placenta; Postmenopause; Premenopause; Sensitivity and Specificity; Testosterone	1996
Hypoglycaemia associated with formestane treatment. BMJ (Clinical research ed.), 1997, Mar-22, Volume: 314, Issue:7084 Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Diabetes Complications; Female; Humans; Hypoglycemia; Middle Aged	1997
Serum sex hormone levels are related to breast cancer risk in postmenopausal women. Environmental health perspectives, 1997, Volume: 105 Suppl 3 Topics: Aged; Androstenedione; Breast Neoplasms; Case-Control Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Prospective Studies; Risk Factors; Testosterone	1997
Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestane. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 1997, Volume: 18, Issue:4 Topics: Alkaline Phosphatase; Androstenedione; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Extracellular Matrix Proteins; Female; Humans; Matrix Gla Protein; Peptide Fragments; Postmenopause; Procollagen	1997
Aromatase inhibitors come of age. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:7 Topics: Aminoglutethimide; Anastrozole; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Nitriles; Triazoles	1997
[Androstenedione conversion in human peripheral blood lymphocytes]. Biulleten' eksperimental'noi biologii i meditsiny, 1994, Volume: 117, Issue:5 Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Female; Humans; Lymphocytes; Menopause; Middle Aged	1994
A novel in vitro and in vivo breast cancer model for testing inhibitors of estrogen biosynthesis and its action using mammary tumor cells with an activated int-5/aromatase gene. Cancer letters, 1997, Sep-16, Volume: 118, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Aminoglutethimide; Analysis of Variance; Anastrozole; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Enzyme Inhibitors; Fadrozole; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Nitriles; Ovariectomy; Postmenopause; Triazoles; Tumor Cells, Cultured	1997
Aromatase inhibitors for breast cancer--further progress. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:7 Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Megestrol Acetate	1997
[Conversion of androstenedione in the lymphocytes infiltrating the breast tumor tissue]. Biulleten' eksperimental'noi biologii i meditsiny, 1997, Volume: 124, Issue:10 Topics: Adult; Age Factors; Aged; Androstenedione; Aromatase; Breast Neoplasms; Female; Humans; Lymphocytes, Tumor-Infiltrating; Menopause; Menstruation; Middle Aged	1997
Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research, 1998, Volume: 4, Issue:3 Topics: Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Cell Line; Chloramphenicol O-Acetyltransferase; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fibroblast Growth Factors; Fulvestrant; Humans; Letrozole; Luciferases; Mice; Mice, Nude; Nitriles; Ovariectomy; Polymerase Chain Reaction; Receptors, Progesterone; Recombinant Fusion Proteins; RNA, Messenger; Tamoxifen; Transcription, Genetic; Transfection; Transplantation, Heterologous; Triazoles; Tumor Cells, Cultured	1998
Serum hormone levels in relation to reproductive and lifestyle factors in postmenopausal women (United States). Cancer causes & control : CCC, 1998, Volume: 9, Issue:2 Topics: Aged; Androstenedione; Body Constitution; Breast Neoplasms; Cross-Sectional Studies; Endometrial Neoplasms; Estrogens; Female; Humans; Life Style; Middle Aged; Postmenopause; Reproduction; Risk Factors; Sex Hormone-Binding Globulin; United States	1998
Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione. International journal of cancer, 1998, Aug-12, Volume: 77, Issue:4 Topics: Androstenedione; Aromatase; Breast Neoplasms; Female; Humans; Lymphocytes, Tumor-Infiltrating; Menopause; Menstrual Cycle; Middle Aged; Neoplasm Proteins	1998
Influence of treatment with onapristone on the IGF-system in breast cancer patients. The Journal of steroid biochemistry and molecular biology, 1998, Volume: 66, Issue:3 Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Female; Gonanes; Hormone Antagonists; Humans; Hydrocortisone; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Protein 4; Insulin-Like Growth Factor Binding Proteins; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Middle Aged; Neoplasm Metastasis; Postmenopause	1998
Severe immune thrombocytopenia during formestane treatment. Haematologica, 1998, Volume: 83, Issue:10 Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasm Metastasis; Postmenopause; Thrombocytopenia	1998
The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity. The Journal of steroid biochemistry and molecular biology, 1998, Volume: 67, Issue:4 Topics: Anastrozole; Androstenedione; Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; Cell Division; Cells, Cultured; Choriocarcinoma; DNA Primers; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Female; Fibroblasts; Fulvestrant; Humans; Letrozole; Microsomes; Nitriles; Placenta; RNA, Messenger; Triazoles; Tumor Cells, Cultured	1998
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients. Clinical chemistry, 1999, Volume: 45, Issue:2 Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Creatinine; Enzyme Inhibitors; Estrogen Antagonists; Homocysteine; Humans; Postmenopause; Vitamins	1999
[Carcinomatous meningitis secondary to breast cancer. Spectacular response to hormone therapy]. Presse medicale (Paris, France : 1983), 1999, Jan-16, Volume: 28, Issue:2 Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Mastectomy; Meningeal Neoplasms; Remission Induction; Tamoxifen; Treatment Outcome	1999
The aromatase inactivator 4-hydroxyandrostenedione (4-OH-A) inhibits tamoxifen metabolism by rat hepatic cytochrome P-450 3A: potential for drug-drug interaction of tamoxifen and 4-OH-A in combined anti-breast cancer therapy. Drug metabolism and disposition: the biological fate of chemicals, 1999, Volume: 27, Issue:3 Topics: Androstenedione; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Aromatase; Aromatase Inhibitors; Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Activation; Liver; Male; Oxidoreductases, N-Demethylating; Rats; Rats, Sprague-Dawley; Tamoxifen	1999
Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Annals of internal medicine, 1999, Feb-16, Volume: 130, Issue:4 Pt 1 Topics: Aged; Androstenedione; Breast Neoplasms; Case-Control Studies; Dehydroepiandrosterone; Estradiol; Female; Humans; Incidence; Prospective Studies; Risk Factors; Testosterone	1999
Aromatase and breast cancer susceptibility. Endocrine-related cancer, 1999, Volume: 6, Issue:2 Topics: Aged; Androstenedione; Aromatase; Breast Neoplasms; Disease Susceptibility; Estrogens; Estrone; Ethnicity; Female; Humans; Middle Aged; Neoplasms, Hormone-Dependent; Polymorphism, Genetic; Postmenopause; Risk Factors	1999
Pilot study of formestane in postmenopausal women with breast cancer. The Medical journal of Malaysia, 1998, Volume: 53, Issue:1 Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Middle Aged; Pilot Projects; Postmenopause	1998
Formestane is feasible and effective in elderly breast cancer patients with comorbidity and disability. Breast cancer research and treatment, 2000, Volume: 62, Issue:3 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Comorbidity; Enzyme Inhibitors; Female; Geriatric Assessment; Humans; Injections, Intramuscular; Treatment Outcome	2000
Dehydroepiandrosterone stimulates proliferation and gene expression in MCF-7 cells after conversion to estradiol. Molecular and cellular endocrinology, 2001, Feb-28, Volume: 173, Issue:1-2 Topics: Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Division; Chromatography, Thin Layer; Dehydroepiandrosterone; Dexamethasone; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Immunoassay; Mitogens; Tamoxifen; Transcriptional Activation; Transfection; Tumor Cells, Cultured	2001
Sources of elevated serum androgens in postmenopausal women who develop breast cancer. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2001, Volume: 10, Issue:4 Topics: Adrenal Glands; Aged; Androstenedione; Breast Neoplasms; Case-Control Studies; Female; Humans; Middle Aged; Ovary; Postmenopause; Risk Factors	2001
Pharmacokinetics and metabolism of formestane in breast cancer patients. The Journal of steroid biochemistry and molecular biology, 2001, Volume: 77, Issue:1 Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Biological Availability; Biotransformation; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Middle Aged	2001
No evidence for the in vivo activity of aromatase-inhibiting flavonoids. The Journal of steroid biochemistry and molecular biology, 2001, Volume: 78, Issue:3 Topics: Androstenedione; Animals; Antioxidants; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line; Enzyme Inhibitors; Estradiol; Female; Flavonoids; Humans; In Vitro Techniques; Rats; Structure-Activity Relationship; Transfection; Uterus	2001
Formestane, a steroidal aromatase inhibitor after failure of non-steroidal aromatase inhibitors (anastrozole and letrozole): is a clinical benefit still achievable? Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:11 Topics: Adult; Aged; Anastrozole; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Disease Progression; Enzyme Inhibitors; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Receptors, Estrogen; Retrospective Studies; Treatment Failure; Triazoles	2001
Ovarian function in patients receiving adjuvant chemotherapy for breast cancer. Lancet (London, England), 1977, Jun-04, Volume: 1, Issue:8023 Topics: Adult; Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Dehydroepiandrosterone; Drug Therapy, Combination; Estradiol; Estrone; Female; Fluorouracil; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Lymphatic Metastasis; Melphalan; Menopause; Methotrexate; Middle Aged; Ovary; Vincristine	1977
Mechanism of action of aminoglutethimide in breast cancer. Lancet (London, England), 1979, Jan-06, Volume: 1, Issue:8106 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogen Antagonists; Estrone; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Testosterone	1979
Steroid delta 4-5 beta-reductase in human mammary tumors. Steroids, 1979, Volume: 33, Issue:1 Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 9,10-Dimethyl-1,2-benzanthracene; Androstenedione; Animals; Breast Neoplasms; Dihydrotestosterone; Etiocholanolone; Female; History, 18th Century; Humans; Mammary Neoplasms, Experimental; Rats; Receptors, Estrogen; Stereoisomerism; Testosterone	1979
Hormonal imbalance in breast cancer. Journal of steroid biochemistry, 1975, Volume: 6, Issue:5 Topics: Adrenal Gland Neoplasms; Adrenal Glands; Androgens; Androstenedione; Breast Neoplasms; Cholesterol; Dehydroepiandrosterone; Female; Humans; Hydroxysteroid Dehydrogenases; Lyases; Neoplasm Metastasis; Pregnenolone; Progesterone; Steroid Isomerases	1975
Plasma hormone profiles in populations at different risk for breast cancer. Cancer research, 1976, Volume: 36, Issue:6 Topics: Adult; Androstenedione; Black People; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Prognosis; Risk; White People	1976
Plasma hormone levels in different ethnic populations of women. Cancer research, 1976, Volume: 36, Issue:7 PT 1 Topics: Adrenal Glands; Adult; Africa; Androstenedione; Animals; Asian People; Black People; Breast Neoplasms; Chick Embryo; Child; Dehydroepiandrosterone; Diet; Estradiol; Estrogens; Estrone; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Infant, Newborn; Japan; Luteinizing Hormone; Menopause; Menstruation; Racial Groups; Testosterone; White People	1976
Biogenesis of steroid hormones by human mammary gland in vivo and in vitro. European journal of cancer, 1976, Volume: 12, Issue:4 Topics: Androstenedione; Breast Neoplasms; Cyanoketone; Dehydroepiandrosterone; Female; Humans; In Vitro Techniques; Pregnenolone; Progesterone	1976
Plasma estrogens and androgens in male breast cancer. Journal of steroid biochemistry, 1976, Volume: 7 Topics: Adult; Aged; Androgens; Androstenedione; Breast Neoplasms; Castration; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estriol; Estrogens; Estrone; Follow-Up Studies; Humans; Male; Middle Aged; Radioimmunoassay; Testosterone	1976
Plasma dehydroepiandrosterone sulfate, androstenedione and cortisol, and urinary free cortisol excretion in breast cancer. European journal of cancer, 1977, Volume: 13, Issue:1 Topics: Adult; Age Factors; Aged; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Hydrocortisone; Middle Aged; Time Factors	1977
Plasma androstenedione levels in women with breast cancer. European journal of cancer, 1977, Volume: 13, Issue:2 Topics: 17-Ketosteroids; Aged; Androstenedione; Androsterone; Breast Neoplasms; Dehydroepiandrosterone; Female; Humans; Mastectomy; Menopause; Middle Aged; Neoplasm Metastasis	1977
Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment. The Journal of endocrinology, 1977, Volume: 73, Issue:2 Topics: Aged; Androgens; Androstenedione; Breast Neoplasms; Castration; Dehydroepiandrosterone; Dexamethasone; Estrogens; Female; Gonadotropins, Pituitary; Humans; Hydrocortisone; Menopause; Middle Aged; Prolactin; Testosterone	1977
Hormonal changes following hypophysectomy in humans. Obstetrics and gynecology, 1977, Volume: 50, Issue:3 Topics: Androstenedione; Arginine; Breast Neoplasms; Cold Temperature; Dehydroepiandrosterone; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Growth Hormone; Humans; Hypophysectomy; Luteinizing Hormone; Pituitary Hormones; Prolactin; Testosterone; Thyrotropin; Thyrotropin-Releasing Hormone	1977
Plasma and urinary androgens in women with varying degrees of risk of breast cancer. European journal of cancer, 1979, Volume: 15, Issue:10 Topics: Adult; Aged; Androstenediols; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Etiocholanolone; Female; Humans; Middle Aged; Risk; Time Factors	1979
Metabolism of pregnenolone by human breast cancer. Evidence for 17 alpha-hydroxylase and 17,20-lyase. Steroids, 1979, Volume: 34, Issue:7 Topics: 17-alpha-Hydroxypregnenolone; Aged; Aldehyde-Lyases; Androstenedione; Breast Neoplasms; Cytochrome P-450 Enzyme System; Dehydroepiandrosterone; Estradiol; Female; Humans; Hydroxyprogesterones; Menopause; Middle Aged; Pregnenolone; Progesterone; Receptors, Estrogen; Steroid 17-alpha-Hydroxylase; Steroid Hydroxylases	1979
Adrenal suppression with aminoglutethimide. III. Comparison of plasma delta 4- and delta 5-steroids in postmenopausal women treated for breast carcinoma. The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:4 Topics: 17-alpha-Hydroxypregnenolone; Aminoglutethimide; Androgens; Androstenedione; Breast Neoplasms; Castration; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Hydroxyprogesterones; Menopause; Progesterone; Progestins	1978
Interaction of delta-5-androstene-3beta, 17beta-diol with estradiol and dihydrotestosterone receptors in human myometrial and mammary cancer tissue. The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:3 Topics: Adult; Aged; Androstenediols; Androstenedione; Binding, Competitive; Breast Neoplasms; Cyproterone; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Female; Humans; Middle Aged; Nafoxidine; Receptors, Cell Surface; Testosterone; Uterus	1975
Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens. Journal of steroid biochemistry, 1975, Volume: 6, Issue:5 Topics: 17-Ketosteroids; Aged; Androgens; Androstenedione; Binding, Competitive; Breast Neoplasms; Dehydroepiandrosterone; Dihydrotestosterone; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Myometrium; Receptors, Cell Surface; Testosterone	1975
Aromatization of androgens by human abdominal and breast fat tissue. The Journal of clinical endocrinology and metabolism, 1975, Volume: 40, Issue:3 Topics: Abdomen; Adipose Tissue; Androgens; Androstenedione; Androstenols; Axilla; Breast; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; In Vitro Techniques; NADP; Testosterone	1975
Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. The Journal of clinical endocrinology and metabolism, 1978, Volume: 47, Issue:6 Topics: Adult; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged	1978
Inhibition of peripheral aromatization in postmenopausal women with breast cancer. Surgical forum, 1978, Volume: 29 Topics: Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Menopause; Radioimmunoassay; Testolactone	1978
Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:5 Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Mastectomy; Menopause; Middle Aged; Steroids, Heterocyclic; Testolactone	1979
Failure of breast cancer cells in long-term culture to aromatize androstenedione. Steroids, 1978, Volume: 31, Issue:4 Topics: Androstenedione; Animals; Breast Neoplasms; Carbon Radioisotopes; Cell Line; Estradiol; Estrone; Mammary Neoplasms, Experimental; Tritium	1978
Androgen-estrogen production rates in postmenopausal women with breast cancer. Cancer research, 1978, Volume: 38, Issue:11 Pt 2 Topics: Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Menopause; Metabolic Clearance Rate; Middle Aged; Sex Hormone-Binding Globulin; Testosterone	1978
Serum concentrations of estrone, androstenedione, testosterone and sex-hormone-binding globulin in postmenopausal women with breast cancer and in age-matched controls. Upsala journal of medical sciences, 1979, Volume: 84, Issue:3 Topics: Age Factors; Aged; Androstenedione; Body Weight; Breast Neoplasms; Estrone; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Sex Hormone-Binding Globulin; Testosterone	1979
Medical adrenalectomy and plasma steroids in advanced breast carcinoma. Surgery, 1978, Volume: 83, Issue:1 Topics: Adrenal Cortex Hormones; Adrenal Glands; Adrenalectomy; Aminoglutethimide; Androstenedione; Breast Neoplasms; Depression, Chemical; Dexamethasone; Estradiol; Estrone; Female; Humans; Hydrocortisone	1978
Factors affecting testosterone metabolism by human breast tissues. Clinical oncology, 1978, Volume: 4, Issue:1 Topics: Androstane-3,17-diol; Androstenedione; Breast; Breast Neoplasms; Dihydrotestosterone; Estradiol; Female; Humans; In Vitro Techniques; Menopause; Testosterone	1978
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma. Annals of surgery, 1978, Volume: 187, Issue:5 Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Estrogens; Female; Follow-Up Studies; Humans; Hypophysectomy; Lung Neoplasms; Menopause; Middle Aged; Neoplasm Metastasis; Prolactin; Radiography; Remission, Spontaneous; Thyrotropin; Thyroxine; Time Factors	1978
Estrogen synthesis and estradiol binding by human mammary tumors. Cancer research, 1978, Volume: 38, Issue:8 Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Age Factors; Aged; Androstenedione; Breast Neoplasms; Estradiol; Estrogens; Estrone; Female; Humans; In Vitro Techniques; Menopause; Middle Aged; Receptors, Estrogen; Testosterone	1978
Steroid metabolism in human breast cancer cell lines. Steroids, 1978, Volume: 32, Issue:5 Topics: Androstenedione; Biotransformation; Breast Neoplasms; Cell Line; Chromatography, Gel; Estriol; Etiocholanolone; Humans; Hydrolysis; Steroids	1978
Relative binding affinity of androstane and C-19-nor-androstane-steroids for the estradiol-receptor in human myometrial and mammary cancer tissue. Molecular and cellular endocrinology, 1977, Volume: 8, Issue:1 Topics: Androstane-3,17-diol; Androstanes; Androstenediols; Androstenedione; Breast Neoplasms; Cytosol; Estradiol; Female; Humans; Myometrium; Protein Binding; Receptors, Estrogen; Structure-Activity Relationship; Testosterone; Uterine Neoplasms	1977
Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels. The Journal of clinical endocrinology and metabolism, 1977, Volume: 45, Issue:3 Topics: Adrenal Glands; Aminoglutethimide; Androstenedione; Breast Neoplasms; Castration; Estradiol; Estrogens; Estrone; Female; Humans; Hydrocortisone; Male; Menopause	1977
Letter: Increased androgenic activity and breast carcinoma. American journal of obstetrics and gynecology, 1975, Aug-01, Volume: 122, Issue:7 Topics: Androgens; Androstenedione; Breast Neoplasms; Estrogens; Female; Humans; Hyperplasia; Menopause; Ovarian Diseases; Ovary; Testosterone	1975
Testosterone metabolism in benign and malignant breast lesions. Cancer, 1975, Volume: 36, Issue:2 Topics: Adenocarcinoma; Adenofibroma; Adolescent; Adult; Androstenedione; Breast Neoplasms; Carbon Radioisotopes; Cells, Cultured; Dihydrotestosterone; Female; Histocytochemistry; Humans; In Vitro Techniques; Mastitis; Methods; Middle Aged; Pregnancy; Testosterone	1975
Oestradiol synthesis from C19 steroids by human breast cancers. British journal of cancer, 1976, Volume: 33, Issue:1 Topics: Androstane-3,17-diol; Androstenedione; Breast Neoplasms; Dihydrotestosterone; Estradiol; Humans; In Vitro Techniques; Testosterone	1976
The effect of endocrine therapy with medroxyprogesterone acetate, 4-hydroxyandrostenedione or tamoxifen on plasma concentrations of insulin-like growth factor (IGF)-I, IGF-II and IGFBP-1 in women with advanced breast cancer. International journal of cancer, 1992, Sep-09, Volume: 52, Issue:2 Topics: Aged; Androstenedione; Breast Neoplasms; Carrier Proteins; Female; Humans; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor I; Insulin-Like Growth Factor II; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Tamoxifen	1992
Tissue androgens and the endocrine autonomy of breast cancer. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3 Topics: Adipose Tissue; Androgens; Androstenediols; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Female; Humans; Menopause; Testosterone	1992
Endocrine status in stage II vs. advanced premenopausal and postmenopausal breast cancer patients. Neoplasma, 1992, Volume: 39, Issue:1 Topics: Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Endocrine Glands; Estradiol; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Neoplasm Staging; Prolactin; Sex Hormone-Binding Globulin; Testosterone	1992
The influence of intramuscular 4-hydroxyandrostenedione on peripheral aromatisation in breast cancer patients. European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:10 Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Estriol; Estrone; Female; Humans; Injections, Intramuscular; Middle Aged	1992
[Aminoglutethimide and aminoglutethimide+tamoxifen treatment for advanced breast cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:12 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Aminoglutethimide; Androstenedione; Breast Neoplasms; Drug Evaluation; Drug Therapy, Combination; Estrone; Female; Humans; Middle Aged; Survival Rate; Tamoxifen	1992
4-Hydroxyandrostenedione treatment for postmenopausal patients with breast cancer. The Journal of steroid biochemistry and molecular biology, 1992, Volume: 43, Issue:1-3 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Menopause; Middle Aged	1992
Endocrine profile in breast cancer patients receiving chemotherapy. Breast cancer research and treatment, 1992, Volume: 20, Issue:2 Topics: Adult; Age Factors; Amenorrhea; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Estradiol; Estrone; Female; Fluorouracil; Hormones; Humans; Luteinizing Hormone; Methotrexate; Middle Aged; Obesity; Prolactin	1992
Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. American journal of epidemiology, 1992, Jun-01, Volume: 135, Issue:11 Topics: Aged; Analysis of Variance; Androstenedione; Breast Neoplasms; California; Chi-Square Distribution; Cross-Sectional Studies; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Sex Hormone-Binding Globulin; Testosterone	1992
Specificity of low dose fadrozole hydrochloride (CGS 16949A) as an aromatase inhibitor. The Journal of clinical endocrinology and metabolism, 1991, Volume: 73, Issue:1 Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Estrone; Fadrozole; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Imidazoles; Kinetics; Menopause; Nitriles	1991
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:7 Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Menopause; Middle Aged; Thyroxine; Triiodothyronine	1991
Measurement of aromatisation by a urine technique suitable for the evaluation of aromatase inhibitors in vivo. Journal of enzyme inhibition, 1991, Volume: 4, Issue:4 Topics: Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Estrone; Female; Humans	1991
[The use of aminoglutethimide in the treatment of metastatic breast cancer]. Minerva ginecologica, 1991, Volume: 43, Issue:12 Topics: Adrenal Glands; Age Factors; Aminoglutethimide; Androstenedione; Breast Neoplasms; Female; Humans; Menopause; Neoplasm Metastasis	1991
The influence of CGS 16949A on peripheral aromatisation in breast cancer patients. British journal of cancer, 1991, Volume: 63, Issue:5 Topics: Aged; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Estrone; Fadrozole; Female; Humans; Imidazoles; Middle Aged; Nitriles	1991
Endocrine status in patients with mammary gland diseases: correlation between steroid hormones and sex steroid binding globulin. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1991, Volume: 5, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Menopause; Menstruation; Middle Aged; Prolactin; Sex Hormone-Binding Globulin; Testosterone	1991
Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry. Journal of chromatography, 1991, Apr-19, Volume: 565, Issue:1-2 Topics: Administration, Oral; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Chromatography, High Pressure Liquid; Female; Humans; Mass Spectrometry	1991
Concentrations of oestrone and 4-hydroxyandrostenedione in malignant and normal breast tissues. International journal of cancer, 1991, Oct-21, Volume: 49, Issue:4 Topics: Aged; Androstenedione; Aromatase Inhibitors; Breast; Breast Neoplasms; DNA Polymerase II; Estrone; Female; Humans; Neoplasm Staging	1991
Effects of cytotoxic chemotherapy on ovarian and adrenal steroidogenesis in pre-menopausal breast cancer patients. Oncology, 1991, Volume: 48, Issue:3 Topics: Acetone; Adrenal Glands; Adult; Aged; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chlorambucil; Cisplatin; Estradiol; Female; Fluorouracil; Gonadotropins; Humans; Menstruation; Methotrexate; Middle Aged; Ovary; Pyrones	1991
Analysis by DNA polymerase alpha activity of human breast tumour proliferation and the effect of endocrine therapy. British journal of cancer, 1990, Volume: 62, Issue:2 Topics: Androstenedione; Antineoplastic Agents; Biopsy; Breast Neoplasms; DNA Polymerase II; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Receptors, Estrogen	1990
Endocrine and clinical aspects of new compounds for treatment of hormone-related cancer in gynecology. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1990, Volume: 118 Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Neoplasms, Hormone-Dependent; Tamoxifen	1990
Effect of treatment with 4-hydroxyandrostenedione on the peripheral conversion of androstenedione to estrone and in vitro tumor aromatase activity in postmenopausal women with breast cancer. Cancer research, 1990, Jan-01, Volume: 50, Issue:1 Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase; Breast Neoplasms; DNA Polymerase II; Estrone; Female; Humans; Kinetics; Metabolic Clearance Rate	1990
Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione. Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Estradiol; Female; Humans; Menopause; Middle Aged	1990
4-hydroxyandrostenedione--further clinical and extended endocrine observations. British journal of cancer, 1990, Volume: 62, Issue:2 Topics: Aged; Aged, 80 and over; Androstenedione; Antineoplastic Agents; Breast Neoplasms; Endocrine Glands; Female; Humans; Menopause; Middle Aged	1990
Androgens and breast cancer in premenopausal women. Cancer research, 1989, Jan-15, Volume: 49, Issue:2 Topics: Adult; Androgens; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Menopause; Middle Aged; Progesterone; Retrospective Studies; Sex Hormone-Binding Globulin; Testosterone	1989
Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer. British journal of cancer, 1989, Volume: 60, Issue:2 Topics: Aminoglutethimide; Androstenedione; Breast Neoplasms; Buserelin; Female; Goserelin; Humans; Menopause; Receptors, Estrogen; Tamoxifen	1989
Review of the endocrine actions of luteinising hormone-releasing hormone analogues in premenopausal women with breast cancer. Hormone research, 1989, Volume: 32 Suppl 1 Topics: Adult; Androstenedione; Breast Neoplasms; Buserelin; Estrone; Female; Goserelin; Humans; Middle Aged; Testosterone	1989
The effect of medroxyprogesterone acetate on aromatase and DNA polymerase alpha activities in breast tumours. Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6 Topics: Aged; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Cell Division; DNA Polymerase II; Estrone; Female; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Tumor Cells, Cultured	1989
Lack of diurnal variation in plasma levels of androstenedione, testosterone, estrone and estradiol in postmenopausal women. Journal of steroid biochemistry, 1989, Volume: 34, Issue:1-6 Topics: Androstenedione; Breast Neoplasms; Circadian Rhythm; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Reference Values; Testosterone	1989
Antiprogestins, a new form of endocrine therapy for human breast cancer. Cancer research, 1989, Jun-01, Volume: 49, Issue:11 Topics: Aged; Androstenedione; Breast Neoplasms; Drug Evaluation; Estradiol; Estrenes; Female; Humans; Hydrocortisone; Lymphatic Metastasis; Middle Aged; Mifepristone	1989
Inhibitory action of androstenedione on the proliferation and cell cycle kinetics of aromatase-free MXT and MCF-7 mammary tumour cell lines. European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:5 Topics: Androstenedione; Animals; Aromatase; Breast Neoplasms; Cell Division; Cell Line; Estradiol; Female; Humans; Interphase; Mammary Neoplasms, Experimental; Mice; Tumor Cells, Cultured	1989
Plasma sex steroids and SHBG in patients with breast cancer and their relation to tumor oestrogen-dependency. Experimental and clinical endocrinology, 1989, Volume: 93, Issue:1 Topics: Adenocarcinoma; Androstenedione; Breast Neoplasms; Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Progesterone; Receptors, Estradiol; Sex Hormone-Binding Globulin; Testosterone	1989
In situ oestrone synthesis in normal breast and breast tumour tissues: effect of treatment with 4-hydroxyandrostenedione. International journal of cancer, 1989, Aug-15, Volume: 44, Issue:2 Topics: Aged; Androstenedione; Aromatase; Breast; Breast Neoplasms; DNA Polymerase II; Estrone; Female; Humans; Middle Aged	1989
Estrogen and androgen levels in women treated with radiation for cervical cancer--possible influence on breast cancer risk. American journal of epidemiology, 1989, Volume: 129, Issue:3 Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Cross-Sectional Studies; Estradiol; Estrone; Female; Humans; Middle Aged; Ovariectomy; Risk Factors; Testosterone; United States; Uterine Cervical Neoplasms	1989
Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. The American journal of clinical nutrition, 1989, Volume: 49, Issue:3 Topics: Androgens; Androstenedione; Breast Neoplasms; Diet; Diet, Vegetarian; Female; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Testosterone	1989
A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients. British journal of cancer, 1985, Volume: 52, Issue:4 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Depression, Chemical; Drug Combinations; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Time Factors	1985
Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report. Cancer research, 1986, Volume: 46, Issue:9 Topics: Adult; Aged; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Dehydroepiandrosterone; Drug Evaluation; Estradiol; Estrone; Female; Humans; Menopause; Middle Aged; Sex Hormone-Binding Globulin	1986
Endocrine effects of low dose aminoglutethimide with hydrocortisone--an optimal hormone suppressive regimen. Breast cancer research and treatment, 1986, Volume: 7 Suppl Topics: Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause	1986
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients. British journal of cancer, 1987, Volume: 55, Issue:3 Topics: Androstenedione; Antineoplastic Agents; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Sex Hormone-Binding Globulin; Testosterone	1987
Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:9 Topics: Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Hormones; Humans; Hydrocortisone; Middle Aged; Sex Hormone-Binding Globulin; Thyrotropin; Thyroxine	1987
High dose ketoconazole: endocrine and therapeutic effects in postmenopausal breast cancer. British journal of cancer, 1988, Volume: 58, Issue:4 Topics: 17-alpha-Hydroxyprogesterone; Aged; Aged, 80 and over; Androstenedione; Breast Neoplasms; Dehydroepiandrosterone; Estradiol; Estrone; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Ketoconazole; Menopause; Middle Aged; Sex Hormone-Binding Globulin; Testosterone	1988
Endocrine effects of low dose aminoglutethimide as an aromatase inhibitor in the treatment of breast cancer. Clinical endocrinology, 1985, Volume: 22, Issue:2 Topics: Adrenocorticotropic Hormone; Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Depression, Chemical; Drug Therapy, Combination; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Oxidoreductases; Testosterone	1985
Subcellular concentrations of estrone, estradiol, androstenedione and 17 beta-hydroxysteroid dehydrogenase (17-beta-OH-SDH) activity in malignant and non-malignant human breast tissues. International journal of cancer, 1987, Sep-15, Volume: 40, Issue:3 Topics: 17-Hydroxysteroid Dehydrogenases; Androstenedione; Body Weight; Breast; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Receptors, Estrogen	1987
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients. Cancer chemotherapy and pharmacology, 1985, Volume: 15, Issue:2 Topics: 17-alpha-Hydroxyprogesterone; Adrenal Insufficiency; Aged; Androstenedione; Breast Neoplasms; Cosyntropin; Female; Humans; Hydrocortisone; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Metyrapone; Middle Aged	1985
Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line. Breast cancer research and treatment, 1988, Volume: 12, Issue:2 Topics: Androgen Antagonists; Androstenedione; Breast Neoplasms; Cell Division; Cell Line; Dihydrotestosterone; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Flutamide; Humans; Piperidines; Raloxifene Hydrochloride; Receptors, Androgen; Receptors, Estrogen; Testosterone	1988
Steroid modulation of aromatase activity in human cultured breast carcinoma cells. Journal of steroid biochemistry, 1988, Volume: 29, Issue:4 Topics: Androstenedione; Aromatase; Breast Neoplasms; Carcinoma; Cell Division; Estradiol; Estrone; Humans; Hydrocortisone; Nandrolone; Tumor Cells, Cultured	1988
Mammary steroidogenesis: therapeutic implications. International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1987, Volume: 14, Issue:4 Topics: 17-Hydroxysteroid Dehydrogenases; Adipose Tissue; Aminoglutethimide; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Estrogens; Female; Humans; In Vitro Techniques	1987
Aromatisation of androstenedione by human breast cancer tissue: correlation with hormone receptor activity and possible biologic significance. Oncology, 1987, Volume: 44, Issue:1 Topics: Androstenedione; Aromatase; Breast Neoplasms; Estrone; Female; Humans; In Vitro Techniques; Menopause; NADP; Neoplasm Metastasis; Receptors, Estrogen; Receptors, Progesterone	1987
Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture. Cancer research, 1987, Sep-01, Volume: 47, Issue:17 Topics: Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cells, Cultured; Female; Humans; Receptors, Estrogen; Receptors, Progesterone	1987
Oral 4-hydroxyandrostenedione, a new endocrine treatment for disseminated breast cancer. Cancer chemotherapy and pharmacology, 1987, Volume: 20, Issue:3 Topics: Administration, Oral; Adult; Aged; Androstenedione; Breast Neoplasms; Estradiol; Female; Humans; Menopause; Middle Aged; Neoplasm Metastasis; Ovariectomy	1987
Aromatase inhibitors and the treatment of breast cancer. Journal of steroid biochemistry, 1986, Volume: 24, Issue:1 Topics: Adult; Aged; Aminoglutethimide; Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Kinetics; Luteinizing Hormone; Macaca mulatta; Mammary Neoplasms, Experimental; Menopause; Middle Aged; Neoplasms, Hormone-Dependent; Ovary; Rats; Tamoxifen	1986
Response of nitrosomethylurea-induced rat mammary tumor to endocrine therapy and comparison with clinical response. Cancer research, 1986, Volume: 46, Issue:9 Topics: Aminoglutethimide; Androstenedione; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Danazol; Dihydrotestosterone; Female; Humans; Mammary Neoplasms, Experimental; Menopause; Methylnitrosourea; Ovariectomy; Rats; Tamoxifen	1986
Endogenous C19-steroids and oestradiol levels in human primary breast tumour tissues and their correlation with androgen and oestrogen receptors. Journal of steroid biochemistry, 1986, Volume: 24, Issue:6 Topics: Adult; Aged; Androgens; Androstenedione; Breast Neoplasms; Dihydrotestosterone; Estradiol; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Receptors, Androgen; Receptors, Estrogen; Testosterone	1986
Aromatase inhibitors and their potential clinical significance. Journal of steroid biochemistry, 1986, Volume: 25, Issue:5B Topics: Androstenedione; Animals; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Humans; Menopause; Ovary; Rats	1986
Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer research, 1987, Apr-01, Volume: 47, Issue:7 Topics: Administration, Oral; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estradiol; Female; Half-Life; Humans; Injections, Intramuscular; Kinetics; Menopause	1987
The relationship between growth and androstenedione metabolism in four cell lines of human breast carcinoma cells in culture. Molecular and cellular endocrinology, 1985, Volume: 41, Issue:2-3 Topics: 17-Hydroxysteroid Dehydrogenases; Androgens; Androstenedione; Aromatase; Breast Neoplasms; Cell Division; Cell Line; Cholestenone 5 alpha-Reductase; Dihydrotestosterone; Estradiol; Estrone; Female; Humans; Oxidoreductases; Testosterone	1985
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. Gynecologic oncology, 1986, Volume: 23, Issue:1 Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocortisone; Menopause; Middle Aged; Obesity; Risk; Sex Hormone-Binding Globulin; Thyroxine; Triiodothyronine	1986
Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients. British journal of cancer, 1985, Volume: 52, Issue:1 Topics: Aged; Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Estrone; Female; Humans; Middle Aged; Oxidoreductases	1985
Hormonal changes in postmenopausal women with breast cancer treated with trilostane and dexamethasone. Clinical endocrinology, 1985, Volume: 23, Issue:4 Topics: Adrenal Cortex Hormones; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Dexamethasone; Dihydrotestosterone; Estrone; Female; Gonadal Steroid Hormones; Humans; Menopause; Neoplasm Metastasis	1985
Oestradiol synthesis by a human breast carcinoma. Lancet (London, England), 1974, Oct-12, Volume: 2, Issue:7885 Topics: Androstenediols; Androstenedione; Binding Sites; Breast Neoplasms; Carcinoma; Dihydrotestosterone; Estradiol; Female; Humans; Microtomy; Middle Aged; Prolactin; Radioactivity; Testosterone; Tritium	1974
Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients. The Journal of clinical endocrinology and metabolism, 1973, Volume: 37, Issue:1 Topics: 17-Ketosteroids; Aged; Androgens; Androstenedione; Androsterone; Breast Neoplasms; Carbon Isotopes; Climacteric; Dehydroepiandrosterone; Estradiol; Estriol; Estrone; Etiocholanolone; Female; Glucuronates; Humans; Metabolic Clearance Rate; Middle Aged; Sulfates; Testosterone; Tritium	1973
The uptake and metabolism of (4-14C)testosterone in human breast cancer growth in organ culture. Acta endocrinologica, 1974, Volume: 75, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Adenofibroma; Adult; Aged; Androstenedione; Androsterone; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Chromatography, Gas; Chromatography, Paper; Chromatography, Thin Layer; Female; Humans; Mastectomy; Middle Aged; Organ Culture Techniques; Testosterone; Tritium	1974
[Relation between testosterone metabolism and dihydrotestosterone receptor in human breast tumors (author's transl)]. Klinische Wochenschrift, 1974, May-15, Volume: 52, Issue:6 Topics: Adult; Aged; Androstenedione; Breast Neoplasms; Carbon Radioisotopes; Carcinoma; Cytosol; Dihydrotestosterone; Female; Humans; In Vitro Techniques; Middle Aged; Oxidoreductases; Receptors, Drug; Testosterone	1974